var title_f11_57_12176="Aspiration of knee effusion";
var content_f11_57_12176=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F60838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F60838&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspiration of a knee effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lateral approach is preferred since the synovial cavity distends laterally in 75 percent of patients. Landmarks include the lateral patella, superior patellar pole, and the iliotibial band.&nbsp;A 1.5 inch (4 cm)&nbsp;22-gauge&nbsp;needle is inserted at an angle of approximately 70 degrees, halfway between the undersurface of the patella and the middle of the iliotibial band. One mL of local anesthetic is placed in the lateral retinaculum and intraarticularly. The needle is advanced to a depth of&nbsp;1.5 to 3&nbsp;inches (4 to 8 cm) and joint fluid is aspirated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12176=[""].join("\n");
var outline_f11_57_12176=null;
var title_f11_57_12177="Nail capillaries in MCTD";
var content_f11_57_12177=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50044&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fingernail capillaroscopy in mixed connective tissue disease (MCTD)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Capillaroscopy showing widening and thickening of the nailfold capillary loops and patchy loss of capillary density (arrow) in a patient with mixed connective tissue disease. This pattern is also commonly seen in patients with scleroderma, but it is rare in those with classical SLE.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert M Bennett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12177=[""].join("\n");
var outline_f11_57_12177=null;
var title_f11_57_12178="Ventilator trigger with COPD";
var content_f11_57_12178=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59751&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59751&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ventilator triggering in presence of intrinsic positive end-expiratory pressure (PEEPi)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 364px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFsAUQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKrahf2enQLNqF1Baws6xK80gRS7HCrk9ySAB3qwc4ODg+teO3vwx8dau9nD4h+JY1HToLuG6e2OiQxeYY3DgblYEcigD2OiiigDl/ife6ppfw/8QajoV3DZ39lYzXSSywecPkjZsBdwGTjgnIHdT0roNNlebTrWWQ7neJGY4xkkDNRavpOna1ZGz1iwtNQtCQxguoVlQkdDtYEZFS6dY2mmWUVnp1rBaWkI2xwQRiNEHoFAwKAOdt/F1x/a+mWGpeGNb0z+0Zmt4J7l7R4/MWKSXB8qd2GVifnbjNdVXK+Mv8AkY/An/Yak/8ATdeV1VABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFecxeMryX42P4eM0Q0GKw8lTHEW8zUG/e+Wz4+VlgikbbxweckqB6NQAUVT1fU7PRtLu9S1O4S2sbWNpppX6IoGSeOT9ByacuoWh0waj56CxMP2jzicL5e3du57Y5oAtUV5x8DPFGoeJfC05164tpNYimW5lSByQkV1Gl1CAGO4KEnEYz/wA8yATjJ9HoAKKKKACiiigAooooAK8I+IHxJv73xJeaBpn2nSVsNQggivre6Tzp5TNDE6+SyMGUC43bT97ZnjFe7188a/rkMnxund7D4f2WoWN7Daxz6rPJ9vmUqhEiBAVzh8LnkEY7CgD6Bso5orO3jup/tFwkarJMECeYwHLbR0yecdqmoooAKKKKAOV8Zf8AIx+BP+w1J/6bryuqrlfGX/Ix+BP+w1J/6bryuqoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiivI/Dvj6/uPi5qNnqVxLB4Zu5ZtM0lJVhVTeWzBZwWHz5Y5KAk5HoeAAeuUUVyPxa1C+074eay+kK7ancolhaFJ/JZJriRYEcP/CVaUNnjp1HWgDrq5+28XaRc+N7zwnDOzazaWiXssYXKiNmxjcOjDKHBwcOpGecYXwju3stGl8I6jtTVvDhFkwJAa5twB5NyFycCRcHGThgwPIxXBeCNG8S3mm33jnRpILnX11zUpY7OQiOLUbMtHC8BYf6ts2qFGPAZBuBDE0AWfBfie6h+L/iHUtXlltNF1zU59BtEuAzRpcWQjSIJIcKvnFrohMfeTAJNbWleKdRtPjpr+mavdXB0K7aGx0zcyeTHdJbRzSR4+8GZZdwJ64I5wAOl8IeHZJvArWHirT4Ybi/ubq/ubSOcv5DzXMk6qJVCnzI96jeuMMmVPANWP8AhAfDqeHbjRoLFobae4N406Tubn7SW3/aPPYmQyhsEOWJGAOgxQB5/oGizeJ7Dx82i3EVtrNh4xmu9OuJC3lpcRQwKVfYQSjDfGw5+V24JGK6iP4s+H7aOC2137RputoP+Jhp3lPM2nEbQ7zOq7VhBdcSnCsGDDI6dT4Q8N6f4T0KDStKSTyY8vJNK2+W4kPLyyN/E7Hkn8sAADUureG7tpre6hjmt5kMckUihldSMFWB4II4waAPO/jVHHqen+EdKmcyaZq3iC1truJG+W4g2SybCR/CWjQnHYVyms6zceFvhn4o8D+KbiVdWTT7q30W9mcN/bEUgdYliwM+cm5I2jxkfIwJDZHYaH8LrbS9a0+WTW9VvND0hzNpGkTuDFZSHcCd/wB6QKrbUDk7BuGTnj0GSKOR42kjR2ibehYAlGwRkehwSPoTQBxs3hG50rV/D+oeFJbe2+xwRaZfW8zOsVxYp93CjP72P5ih/wBtwTg8drRRQAUUUUAFFFFABRRRQAV836+w0T4u3wt9Vu7WO/1eCR4n8KC5RpGEa7VuWbjOByoGCScZr6Lu5JIbWaWGFp5ERmWJSAXIGQoJ9elfPOpR+J/E3jmxk1vQfGcWmNfQXX9lm/tRbx+Wy4bA+YqGG44OfegD6LooooAKKKKAOV8Zf8jH4E/7DUn/AKbryuqrjviDd2+n6r4MvL2ZILW31WaaaVzhURdNvSzE+gAJrP8AhN49fxhb3kGqwLYaxGRdpZN977FMBJbyD+98jKrEdGBBA4FAHoNFFFABRRRQBXF7am/ayFzCb1YxM0AkHmCMkgOV67SQRnpkGrFeIWtrrs3iHV/iVotot5cQ6ld6b9gSYyvd6XE0UJEJOAsglt5ZVUcEyMMnIz1j/GTwV9nikh1OW5kKGWaC2tpJpbSNcb3nRVJjVM/MWxigD0OioLG7t7+zhu7G4iubWdBJFNE4dHUjIKkcEH1qegArzj4vTT6rceHfBlhfy2Fxr123n3EEhWWK2hQyyFQP720Jlsr83INQ+FfiJcXHjXVNK8R26WFjd381toVwXDLcGB2gliZgBtffEXVTyRJgZwMujn8/9o+WJQCtr4WAZgM4Z7sHBPbhAcd6AOh+Hnik+JNIaLUYvsfiPT9tvq+nsu1ra4xyQNzZjbBZGBIZSOc5x1Vcn4x8GR67e2mq6ZfzaL4itMJFqVsoLPFuDGGVeBLESM7W6Hkd887F4q8U+Cif+FkW9peaLwF1zSYX2wkk/wDHxDyyjHO9flHAPJzQB6dXMfEzWbnQPAWt3+nmb+0ltzDY+TF5rm6kIjgATB3EyOgxg1k3vxd8D21xHDFr1vfE5Mj2Aa5SBAQDJK6AqiAso3Egc+xxX+JqnXh8PV0q9LWd14itLrzLd9yXEMUM1wOhwyHylbuOARnAoAsfDDXJo0n8H+Ibu4m8T6LuR3ulCve2m8iG7Q7jvDJsDHJIfIbBIzznwk8Jadr/AMAfD+naiJENzH9uF1bSGOeG4MrOs6SDkSKcEH2wcjIruvGngfQfGS2n9t2sjTWrEw3EEzwyop4dA6EHawypHcHscEbumWFppWnW1hp1vHbWdvGIooYxhUUDAAoA4C4n+KWm2SxQWnhzWGsE3SXUkjwS6oAV+VYwNtvIV3fMWdN2OADxi+OfHFj4m03wjp+guzajqHiCwW70qcCO8tUik8+TzYT8ybPJGT0xggkEE+xVnjRdLGstqw06zGqsgjN55K+cVGQBvxnHJ70AZ/iXwraa3d2t+k9zp2s2gK2+pWZUTRqfvIdysroe6spHcYOCLPhPQLPwv4ftNH00zvb24Y+ZcSmSSR2Yu7ux6szMzHoMngAYFa9FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAE4GT0r54g8MP4z8fya94cuND1S0m1KC/j8QRag5u7KFCmbYRA8ZCMoBwMOc19DHODgZPpXgemfCjxJ4h8Y2PifX00TwlJbTLMLXQYz9omAIO2aUEKc4wcZzQB77RRRQAUVzHjXWtQ0640HTtF+yJf6vem1Se7jaSKFVhklZiispY4jwBuHJ68czeANduPEXheC/vYoo7sTXFtMIgQheGZ4mZc5OCUyBk4zjJxQBk/E3TbbWbnwnpd8rNaXupXFtMqttJR9MvVYA9uCea0/FXhCx8QSWV351zp+sWB3Wep2jATwdMj5gVdGAwyOCCCeM4IxNR12DxB4p8HR6bZa3/oupy3E8lzo13bRxx/YbpMl5YlUfM6DGcksK7+gDhz4d8bSzLPN46gjkiSMRQ22ixpBIytlzMryO7bhxhHjx1FRz3PxMubYRWum+EdPuY877ma9uLqOYiIkbI1jjKgyFQSXJUBjtbjPeUUAcLN4016GaTT28Ba5PrCQySgW81ubJ9rbVxdO6jDHnaVEgGSY8dZG8ef2S/2fxjompaTcl1SOW0gl1C1uGZmVRFLEhbccL8siRtlgAG6121FAHDfBDRbnw98KPDen36SR3gtvPmjkDB0eVmlZWDchgXwQehBrucUUUAcRefDjTg2oHw/qmseG01Eu15FpE6RxzOwALhXRxG+FHzRhGPcnjDk8GXuj3hufCXiK+s/MCpNaas8uqWzgb/mAklEqPlhysgUhRlSeR2tFAHK6V4KsI/BS+HfEBTXopWlmvJbuBALiaWVpZHCKMJ+8dioHK8YORmtLw14a0rw3DcR6RbvGbmTzZ5Zp5J5ZWwFBaSRmZsAADJ4HStiigAooooAr6fY2mm2iWunWsFpaoWKwwRiNFJJYkKOOSST7k1gaT4D8M6PrEWpaZpUdtcQh/IjR38i3LgB2ihz5cTMBgsignJyeTnp6KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorCuPFuiW5ufOvgi217Hp8zmN9iXEm3ahbGP41yc4BYAkUAbtFFFAGZ4g0LT/EFpFb6pDJIkUqzxPFM8MkUgyA6SIVZTgkZBHBI6GptG0uz0XTINP0yAQWkAISMEtjJJJJJJJJJJJJJJJNYXxHvtLstAX+2L5bJZZQsEkmpz6bG0u1iFe4h5RSAeuQTgYJxUfwlvLi/wDh5o1xeXFzczsjhprgks+JGAIYkl1wBtc8suGPJoA66iuPXxB4js9c0Sz1zQ9IgttTuntFms9VkneN1glmBKNbxggiEj73cda7CgAooooAKKKKACisvwzr+m+J9Et9X0S4a40+cuI5GjeMko5RvlYBhhlI5HatSgAooooAKKKzP7d04eJh4fNwf7WNob8QeW+PJD7N2/G37xAxnPfGKANOiiigAoorlPiF4nuPC8fh5rW2in/tPWrTS5PMYjy0mYguMdSMdDgc/gQDq6KK4n4NeI9T8WeALLV9c+z/AG+Wa4jkEERjUbJnQDBJPRaAO2pGZUALsFGQMk45JwB+dLXH/FcZ8IxDGf8AibaX/wCnC3oA7CiiuF+E/ifUvE8HiltW8jfpuv3emw+THsHlRbNueTk8nmgDuQwJIBBKnB56Glrhfhi5k1bx+SH48RyL8zljxa2w6ntxwOgHA4Fd1QAUVwPwvmlfXPiBG7OyR+IH2FmJxm2g4Geg9veu+oAKK4X4seINR8PWvhd9KuFga98QWVjOWjV98MjEOvPTIHUYPuK7S9lNvZzzKAzRxs4DHAJAzye1AE1FYvgnVpte8G6Bq90kcdxqGn293IkYIVWkjViBkk4yeMmtqgAooooAKKKKACiiigAr5g8UanF/wtnVLeJr9NBTWLWW4003qbL28We1QssewsoHmI+3d82wngcV9P181+KrnVx8bRfR+G7OS607U4VN0+m7muLeRoI4kWXGN4Vp339R5eOAMUAfSlFFZ+t63pWg2qXWuanY6bbO4jWW8nSFGcgkKGYgZwCcexoA0KKQEMAVIIPII70tAHK+Mv8AkY/An/Yak/8ATdeV1Vedaxo19p3i3wPNeeJdX1WNtWlUQ3kdqqKf7PvDuBihRs8EcnHJ46Eei0AFFFFABRRRQB53+z+MfCvTRtVcXV/8q4wP9Mn4GK9Erzr9n5g/wp0xlIIa6viMf9fk9ei0AFFFFAHM+BvFJ8Ux66xsWs/7L1e50rmTf53ksB5g4GAc9O2DyetYMn/Jw1t/2K0v/pXHVf4GyI8HjpUZiyeLtTVgex3qcD8CKsS/8nC23/YrS/8ApXHQB6JRRRQAV518al3WXg84J2+KdMPGeP3wHP516LXA/GIE6Z4YwCQPEul5x2/0lKAO+ry79md3l+DukyyEl5Li7Yn1JuZcmvUa8q/ZlbPwotY8YWK9vEXnOR57n+tAHqtch8VTjwlER/0FtLH/AJP29dfXHfFg48IRnBONW0vgf9hC3oA7GvLvgREYP+FhRnPy+L78jPUgiI/1r1GvNvguHW6+IYdSp/4Sy8OD6eVDg/iMGgB3wbRo7z4hhmLH/hKrpsk54MMBA/DOK6LRvF1tqnjbxD4ZitrhLrRkt3lmbHlyCZNy475FZHwtXbqnxAB/6GSU/na2xrB8DMV/aF+JqA/K9tprke4hwP50Aavwrz/wk/xG4OP7e69v+PaGvRa80+FUq/8ACbfEyDcd6aykhXsA1vHg/jtP5V6XQB5j8d8Gy8EA8Z8WaaM+nztXpF6paznUdTGw6Z7V5n+0E7RaF4UnQ4eHxNp8i/UOa9NuWCW0rnOFQk4GT0oA5r4T/wDJLPBv/YFsv/RCV1Vcr8J/+SWeDf8AsC2X/ohK6qgAooooAKKKKACiiigCK6h+0Ws0Ilki8xCnmRHDpkYyp7Edq888j4i+FlH2e5sPGWnJgCO5xZXwHQASD9259yFJ9a9IOcHbjPbNeJ654c+LniiOxsfED+B002O+t7qU2bXQlxFKr4XcCO3egD2Wwne6sba4lt5LaSWNXaCTG6MkZKnHGR04rlfixZ6jqHhFbXR9MuNSumv7OUxQyRIVSK4jmZiZHQdIyAAScsO2SOxooAQHIBIIJ7HtS0UUAedax4s8Oa94t8D2uh6/pGpXKatLI0VneRzOqDT7wFiFYnGSBn3Fei1xfxGv7bStQ8H6hfyiGztNUnnnkIJCImm3rM2BzwATxXX2lzBeWsN1ZzRXFtMiyRSxMGSRGGQysOCCCCCKAJaKKKACiiigDzD9meVp/gp4fldg7yPdsWA4JN3Mc9q9Prxf9lPxTYa38NxpNujwajpM0jXUBj2qqzzSyxsh6FSCR2IKnjGCfaKACiiigDyv4Btn/hYw4yPGWpf+06vzZH7RFp6HwrN+l3F/jWf8Av8Amo3/AGOepf8AtOmeI9attJ/aH0BbqQRJcaG9ozsjsN0tygiXKg7SzpgFsKemc4FAHrFFFFABXn3xlkdNP8KKhAWTxPpatlc5H2hTx6cgf5Neg15z8cJZotG8OtaWd3f3Meu2t0lragGSZbffcSKoJGT5cMhAzkkADk4oA9Gryn9mfYfhehjYMn9o3m1gMZHnNg47V6N4e1WDXtA0zV7NJUttQtYruJZQA4SRAwDAEjOCM4Jryn9mbUYLbwmPDkyzR6hHv1OLzEwtxaTyMYpkwTwehBwwPUUAezVwfxwuHtPhzdXMRAkhv9OkUkZGRfQEV3leffHiwuNW+Gl7ptlKkN3e3lhbQyuMqkj3kIViPTcRng8djQB6DXl3wIDj/hYYlYtJ/wAJff5JPtFj9MV2vgjXh4o8IaPrgtzbfb7ZLjyS+/ZuGcbsDP1wPoK8/wD2fr61muviRawzq9xF4svZnjJ+dUfaFY+xMb4/3T6UAdF8Mijat4/8tiy/8JHIMn1+yW2R+ByK5/wX/wAnF/EX/rx0/wD9F1a+DesWd54n+JenW8ryXFt4geeQkHAV40jABPXDwSjHbA61V8F/8nF/EX/rx0//ANF0AP8AhO4PxT+K8eOV1C0b84T/AIV6vXjPwvuprf41/EGFrcG11O4Z4p/M5D2iwJIpTH/T0mDnseK9moA8o/aOyPCWhPjITxBYsc+m816rN/qX/wB015P+0t/yJuh/9h+y/wDQjXq8zrHE7yEKiqSxPQCgDlfhE4k+FXg4gEY0e0Xn2hUf0rra8z/Zw1OPUPg/oMaiZZ7KIW08cykMjYDr16q0bxupHG11r0ygAooooAKKKKACiiigAryj4hfEiXSddg0BGu/D+oSXkcdpf3unm6sr4MMCPKMGXLHGeCNvpnHq9fPWuaBJJ8fRc6bqvhzw/fvcRSOs92Lq8vkAUnbC4IjyAQACD3A70Ae/2X2j7Hb/AG4RC78tfO8knZvx823POM5xntU1FYus+LPDmiXi2ms6/pGn3bqHWG7vI4nKkkAhWYHGQRn2oApeNda1DTrjQdO0X7Il/q96bVJ7uNpIoVWGSVmKKyljiPAG4cnrxzN4A1248ReF4L+9iijuxNcW0wiBCF4ZniZlzk4JTIGTjOMnFXvEGhaf4gtIrfVIZJEilWeJ4pnhkikGQHSRCrKcEjII4JHQ1No2l2ei6ZBp+mQCC0gBCRglsZJJJJJJJJJJJJJJJoA4fV/EtjrPi3wPb2cGrxyLq0shN5pN1aJgafeDh5Y1UnkcA56nHBqX4MT7tD16yjGy307X9RsreMcLFEk7bEUdlUEADoAMDitbxl/yMfgT/sNSf+m68rzj4e6frmra94103SNdbRdHs/Ed3NdT2sSS3V3LIzOUUyArCiAxD7rliG5UHFAHqMPjTw5N4nbw7DrNm+tqSpsxJl8hdxH1C8kdRUeteOvDGh67b6Nq+t2dpqdwEMdvK+GO4lV9hkjvWXJ8NtKXwXb6BaXN1FPbXa6jBqkwjnuheLL5v2hmdSGctncccqSvANTxfD3SP+EX13Rb2a91A64HN/f3jpJczMy7VbO3aCihQgCgLtBxnJIBq+J/Fvh/wt9lPiLV7PTftRYQ/aJAnmbQC2PpkfmPUVLN4i0hfDL6+dStRo3kef8AbN4MezHXPf6dc8daztB8GW2m389/qGoX+u30sAtVn1QQu0UOSSibI0ADFstwS21cn5RjGs/hTotpMsMd7qj6El4b+PQXljNhHJncAqbNwQP84j3bd3bkigDmfhNpl1pmteBZzdzmC/8ABCRy2zHADwSwOrEeoF26j0Ga9N1DxVoOm63b6PqGs6fa6pchTDazTqkkm4kLtUnnJBA9TXF/EfUNZtPib4ItPDkdp/aGpWeo2n2i7V3itYw9pK8pRcFztiKqu5QWZckDq7UPhPaax4d1+DXb6K88RaxL58mspYxxSW7qEWIRKMsqIIkGC5J+Y7stQB6Bq+p2OjadPqGrXlvZWMABknnkCImSAMk8ckgD1JAqGx13SNQ0l9UsdUsbnTEDFruG4R4VC/eJcHAx354rj4Ph7e6pqUF3488Ry+IobaUT2+nrZpa2aPjAZowWMhHUbmIBJ45qCf4UWL6pfxwag1r4Uvri3vbjw9BZW4t5LiEx8klD+7cRR7kABJBO7BxQByn7OmqSXfij4mRJLFJpcmttqdm6fxrcSTLvz6MsSEe3PQ1lfFlG1XxZ8T5fkltdL8KQQMUk/wBVP5rTx5AOQ4Klh6YHrWxYaHrkPxl8d6f4Nv8ATdHtbnT9PlluWshcfZCkRigiih3ooOFkfcdyjCDb69ZrXgrTfD3wd8S6LpMbEzaddNcXUwMk91K0bFpZW6u5PP5AYAAoA9BtpVuLeKZDlJEDgj0IzUleT+Crzxn4z8I6PcWFxa+G9CmtVVLiWFp9SnRWChwjARw70UsDmUYdSM9a1B4F8RaXLqJ8LeNZ7SLUAJJv7TshfulxjDTRHeipu4JTaUBHCgcUAdx/aun/AG42X2+0+2Zx5HnL5mcZ+7nPSuT+I8KXevfD+2MirJ/b/nqu7BIjs7lifpwM/UetZmqfBvwzceE5dMsIFtNZOJY/ELxiXURchxJ57T8Ozlxk4YdSBtGMa/hnwVPaeJ7rxJ4n1VNc111MFrKtoLeKxt8kmOKPcxySTlyxYjA7HIBQ+Ast03wo0Jb+SQvaC5s/3mAVSG4kiRTgDlUjUZx25rzz4AOy+JvCySMWaTwQhz7LetgfgGArV0KLVPHena94Stra3g8OWfiO8h1jUJp3WS5H22a4e2gjjIIBVoVaRmXAkcKrYzU3ijUk8H/GiwGlaSs9xP4bXTdL0y2AhWaT7SW2q2NqJGi5Y9geAaAPZJ7u2t5YYri4hikmO2JHcKZD6KD1P0rgPjVdmC28GW6jc114p02PAznCy+YTj22VgeNfhrrXirSvE2s6u1kvit7WJNETT3LfYGgcyoI55AhDyPgM+1MDgcV1+g+H9avfFp8SeMxpQuLON7bSbKw3TJaJJtMsrSuis0r7VXhVAVeM72oAz/2drl7v4LeFpJWDFbdogR/dSR0X9FFcj8FIrYeINGvLVkd9QtdfnklUL+8UanCqZYfeA+Yjk43tjg1mfDJfEV18KX8AeG7ezN1aR3VjqWq3U5SOxeSUsYljUF5JljlbOQqKy43MQRXQeMJv+EC8ReGtO8MWcl1qA8OXumaNaKgZprjzbTZu+6NoCmR2JACq5oAyvhNdeV8cNXtrJoxZ6hpuo3s/l4xNImt3SI5I6kIxGfTFbXhS/tk/ab8bWUPzSTaVaSStuzh0Cjb7fK68e3vWXqllD8MPFHhKPR7N9T12TwvPoVjBbwbReXMctu6swzhFJaaR2LfKoYkk4zz50uT4Y+NfDtlZ2aza3c+FpbOFbd8/2hqryqzHe+D1yxdyAFAAA+VSAbngjVo4fjVLCskOLzVtetBk8krHp7kLjv8Auj+APeveGdVIDMAT0BPX/OR+deDXui2vw6174M2d9OGj0/8AtFLi4WPcZp5LYkhQo3MzuSFUAsxKjBatPxL4Tu/iLpviHxHqehajZX8emrF4asrm5MFxDKqNKJ2WOXbG7StGu1uR5C7sZwADe+N+nw6vbeD9Mu3lS3vPEEMTtDJsdT5E5VlPZlcKw919M03wf4rudU/Z/i8SaxKWuRo80txMq8sY1cF8DudmTjjJqx4W0+88TeN28Za7oU+m21vYxWuj22ouGuIi2XmnMSkrCzb0jxkyYiOdoO0+c/DC0vvFPw28JeD7e3kGlWD+dr9wwBikVJ5GFkpJyzsVXeMYVGGT8wBAO7+ANrPZeGtQtbuNormCSwiljYYKMukWAIPuCK9Prx/X7+4l1Dxr4W0hbk6z4h1cWsUsMRYWlv8A2fYLPdO2VCiNZBgbgWdkUdcj2CgAooooAKKKKACiiigCK6nitbaW4uHCQxIZHY9FUDJP5V83XVx4O1nx6zWXjnw82l6lq0GovEbLN956shWOObHClkUeoDEfX6UlXdE64zlSMV84fDGw+Jnh7WbM614Elv7Zre3tJJbjWIG8plkYvc4yxLEOMgc/IOT2APpGvL/E2leIofiVfarpkPiIWFzp1rbiXR2075njknZhILs5AAkXBQdznoK9QooAKKzde1OXSrWOW30u/wBUlklESwWSoX5BO4mR0VVGOpYdh1IpPDWtW3iHQ7TVbFZUguFJCTLtdCCVZWAJGQQRwSOOCaAON1i28Rw+LfA7a5qukXlsdWlCx2emSWzh/wCz7zBLNcSAjGeNo6jnjBPhhbLZ+MviTDGNqHWY5sZJ5e2icnn3atvxl/yMfgT/ALDUn/puvK2dN0XT9Nv9TvbG3WK51KVZ7pwx/eOqKgOM4HyqOmM9epNAGjRRRQAUUUUAcTr8Al+Lvg5zFvMOm6o4bONnzWi59/vY/Gu2qlNpdpNrFpqkkZN7awy28T7jhUlMZcY6HJiT6Y96u0AFFFFAHK6VpN9bfErxFqs0IGn3un2MMMocHLxvcb1I6gjzFPTBz1zkC/46kMPgnxDIpIZNOuGBHbEbVt1S1qx/tTRr+wMph+1W8kHmBQxTcpXODwcZoAwvhP8A8ks8G/8AYFs//RCV1VZfhbSF0DwxpGjJMZ006zhtBKV2lxGgTdjtnGcVqUAFFFFAHBfB6xt7TTPE01uHEt54l1SefceC4uXjG322xp+Oax/FO0/tFeB+QWGl3xwR06c5/Ou88KaPJoenXNtLcCfzb+8vFIXaEWe4kmC++PMxmud13w3qV58XvC3iC3ihOm2FldQXEjS4cNIBtAXHPTr9fQZAO7ooooA8/wDg5bwxaf4okiiVZZvEuptK4HLkXLqCT3wAB+FYvxB/5OB+E/8Auar/AOk1dj8PtEvNDstZivxGGutZvr2LY27MUszOmfQ4PSsfxf4c1PUvi78P9as4FbTdJj1D7ZMXA2+bCqIMdTk+noaAJfE+lx6h8YvAtzITu06w1W6TB7n7LFz+Epqn4mVH+O3gjKqXTTdRbPcZ8oA+3f8AM10OoRSH4m6BKEcxLo+oqzgfKCZrEgE+p2n8j6Vk+INOvZvjJ4R1CK1next9Pv45p1TMcbN5W0E9icHGeuOO+ACr8U9Ih1jxd8NobjcFi1xrkMhwd0VvLMozzwWjXI7juOtej1xnjY/8Vp8PR3/tS4/9ILmuzoAK8z/Z1to4/hlBdoMSX99e3UvJ+8biRe/ThFHFemVy/wAMvDdx4R8E6fol7cxXNxbNMWliUqrb5XcYB54DAfhQByHw8RT8efi25Vd4GkgNjkA2zZH6D8q9XrznwPpN/Z/GH4majdWk8Vlf/wBmfZZ3TCTeXbsr7T3weD6V6NQAUUUUAFFFFABRRRQAUUVxOm/FXwTqfik+HbHxDazavvMYiCuFdx1VZCNjH2BOe1AHbUUVW1L7Z/Z9z/Zn2f7d5beR9oz5e/Hy7tvOM9cc0Act4g8EiTSJbLwbLp3hlrq4WW9kttPH+lIAco3lvGwzkfMGDYyARmug8OWE+l6JaWNy9iz26eWv2G1NtCqDhVWMu5UAYH3j07dK8+tfGniS4mt9Ogk0W4nvtXOn2erpayLaSIlu80rCLzSzFTG0YIkAJ7/KRXZeANduPEXheC/vYoo7sTXFtMIgQheGZ4mZc5OCUyBk4zjJxQAul+CvCukX8V9pXhrRLG9iz5dxbWEUUiZBBwyqCMgkfQmugrlbfxdcf2vplhqXhjW9M/tGZreCe5e0ePzFiklwfKndhlYn524zXVUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBVutPtbu6srm5gSSezkaW3c9Y2KMhI+quw/GrVFFABRRRQAUUUUAFFFFABRRRQAUUUUAR3MIuLaWBmZVkQoSpwQCMZHvXgZ8N+I9K0/wAP+FPFE3hDS/C2nXlv5OrmYRXNz5Lq6KiNwszbAGP+917648ZatB8e28Opq+NMmfJs5Hiuix8rOFEah7ccA/vGOeuBkVm3vjFvGPjXTdN1n4a629zYIRNb3DQyRpDcYQvIrA8DZkEEHg+tAHudne216kj2k8cyxyvC5Q52uh2sp9wQRUes6ZaazpV1puoxtJZ3UZimRZGjLKeo3KQR+BrM8EeF7Pwfoh0vTpriW28+WdTO+9l3sW256kDOMnnjmt+gDlI/AGgJpi2Bj1OS2jkjlh83VruR7dkBCmF2lLREBiPkK5Bwcit7RtLs9F0yDT9MgEFpACEjBLYySSSSSSSSSSSSSSTV2igDifiXqVto134S1O/cpZ2WpXFzMwUsVRNMvWY4HJ4B4qx8OPHFv430+7nj0+8024tZVWS1uwN4jdFlhfgkfNG6NjqDkc4BOB4pvJvEeueEdL1rwrqthYXGo3EcrX0tq0cqtp14rR/uZ3bJDHsBgHnOM6fgfj4hfEYZyPt9oceh+ww0Ad1RRRQAUUUUAcHoHxJsde+KGreD9Lt2nXS7Vpbm/DEKk6yBDBtK8kA53Z7MMcZrvK+ePhpssPi+0rFYptT1vxLEWdgWnCS2pVRxnA8snHP3WPevoegAooooA5fQPF8WseOfFXhtLR4pNBFqXnLgibz4y4wMcYxjvmqXxT8cHwVpNs1pp8uo6vqEhtrC1XhZZsZClvUjOAOWOAMZyOd+Hn/Je/i1/u6T/wCkxqP4seZP8Ufh9BE7qUt9Xn3L/wAs2FsAknpuBbg9s/SgD0nw1q0eveHdK1eCNo4tQtYrtEY5KrIgYA/nWkea5T4T8fCzwd/2BbP/ANEJXV0AFUdc1ay0LR7vVNVnFvYWkZlmlKltijqcKCT9AKvV5j+0vdTWfwQ8Ty28jxuyQRMUbBKPPGjrn0KswPsaANr4OeK7zxv8N9I8Q6lDbwXd552+O3BCDZM6DGST0Qd+tc/afEhNS+PR8I6VfJc6fBp0gvIxFjyrtHzgP1JC8EdAe+cgbHwemifRvEEELDba+ItUh2DgR/6VIwUDtwwP415V4JtoV+MVnfRpEl1L4l8RQTzBf3jhY08sM3dVUHA4Az0zk0AfSNI7KiM7sFRRkknAAoBDAEdDyK5b4sf8ks8Zf9ga9/8ARD0AZvwS8W6h42+H9prerpbJdyzzoRbAhMLIyjGSew61HdfEHb8ZrLwTbwwmE2LT3NwxJYTkF44l7A+WjuQc5HTG05i+BtpBp3hrWtPsohDZWWv6jb28S5xHGtwwVRnniuH0nDftE68y4I/4SCxXcO5Gi3uR+FAHor+J71vjdD4VUounJ4efU3wAWeVrlI1ycZAVVboed5znAxR1LxJqsPx60jw5FdAaNPokt3Jb+UvzSiQgNuxu6AcZxXLaddOn7Ud9JOVbzrWbTIAnDKqW9ncHd6jMpx+NaWr/APJ0eg/9i3L/AOjmoAu+MfEd1H8c/h/4fstRdbeWK+ub6ziY/MBAwiMn+zkNgeoz6V6hXil3GjftFiVo0MqXVgiuVG5VbTtULKD1wSqnHsK9roAw/G2vN4Z8L32rR2T380AURWqOEaaR3CIgJzjLMB0P0PSqnwz16/8AE3gjTNV1e3httSmEiXMMOdsciSMjKMkkYKnIyec1m/GsBvh3dqwBVrywUg9wbyEGovgfhfAIhXYFh1LUYwq9VAvJsA/n+WKANDwV4ml8QeIPF9upifT9M1BbO2kUFXJWJRKCDyQJRIobocEDO2uuryj4PZ/4S3xXltxw/wA2MZ/4m+r816vQAUUUUAFFFFABWB4u8Y+H/B9vbT+JdUt9PjuZPLiMuSXbvgAE4HGT0GRmt+vO/in8P9S8Y6hpF7o3iCLRbixhuIGMmnpdiVJvLyMOQF/1fXGee1AGNb+HvF7fFVdc0/Ud/ha+uBOy2txGkJgEGAWUJukZmKkENxtOeCMP0z4I2un67HqyeNvHEt4rR+Y0upg+cqNuVHOzLJyeM9z611Xwv8L6v4Q8Nx6RrPiEa3HbhIrRhZrbeRCiBVjwpO7p1JzXiepWlpffGnW5bzTdOvJINZhSObU/ET2k0QCRHEUKsA6AklRg5zg+lAH05RRRQAUVwvxVsvtieHWvtPn1PQYNS8zU7OG2a5MkfkyhC0SgmRVlMZKgHoDjirnwotLyx8C2MF/DNbsJbhoYJlKvFA08hhQg8jEZQbT0xjtQBJ4y/wCRj8Cf9hqT/wBN15WZ4FZT8R/iSgI3C+siR7Gxh/wNV9XtvEcPi3wO2uarpF5bHVpQsdnpkls4f+z7zBLNcSAjGeNo6jnjBXV9B8QaB451HxP4O0/TtRXWYYItTsrq5e3kMkIdY5klwygbWCsu3+EEck0AeiUV5tD8UVuNNFrFpDxeNBdpYP4duZ9kqyn5i3mKrAwiMPIJQNpVeOTirsHxBa28P+IbnxHo8mka1odm99c6abhZRJDhzG8UoAV1fy2XoCGBBHQkA7yiuF0LxtqZ8R2uieL/AA2+g3d8rmxmS8S6guGQZePeoUq+35gCOQG9Ocdfi4Gv7u6Tw3qMng62uXtJfEEbq0aMhAdzF9/ylY4L8jAJ7GgDm7DTZm8ffDvUhkwReIvFELccBpJLkqM/9smr3avLbTRdT1bwT9o8O3cVrruleI9VvrEzoHhlkF7eRmOUddjpK6kqQRkEHird38T00TSdek8W6U2l6xpFql6+nw3K3JuIZG2I8TALuG/5Gyo2nrwQSAej0V5ofiNreiywTeOvBs+h6PMUQ6lb38d5Fbu2MeeAqmNQTgvgjPHTmp9f+I1xpPiHVrdPDl5d6Hooj/tXU4pQPsxeIykrERmRUQoWIbI38Ke4Bh+ArjZ+0b8UbYsv72DTpAuDk7LdQefbePzFaHj1DL8YfBax4Zl03VC6YOdpjjAPoeePXmsfyNYPj/X/ABX4T0601ma1vpbV7Q3gtzcRS2GnujpIQVOPK4B4IfqMZq1oviGDxT8XNC1C3t5baS10jUre7tJyvn2ssdxArK4UkdwQc8hs0AdX8F7uK8+EvhCSFtyrpdvETnPzIgRh+amuz715TpsXjH4d299p+m+HLDXvDMdzLPYrYXBgu4UmmeRo2jcFX2mTAKso2rk8nAuP8S9Vuorl9E+H/iW6No4iuY7pYrV0cjIChmO8YwSVyAGXrngA9Krz34/2X9ofCXW7TarmVrYBWOAT9piIBPpmrsfxI0dvCWo65JBqELWNwbKbTpIM3YudwVYBGpILuWXbgkHcDnGSOH+IfjabWPBt5pOreG9Y0PUpJLOdYbpUdJ4hfWySCN0Y5IMqjBwfmB+gB1vwlsX0298fWrlsf8JPczruABAmhgm7dv3hx7YrzLwg32f4kaVOxIjl8a+IYnbsGaEhR9TsH616D4kn1/wJruveJrS0TVvC14qXuo2wlWO4snijSOSaL5cSKYY1JQkHKcEZwee0Dwlc6/4c8QnTbiC21nT/ABrfatYvcIXhM0czbUkAOdjKSCVII3ZGSMEA9trkfi9t/wCFU+MdxAH9j3fU9/JbFc9c/E270HRdd/4TPRV0nW9L05tQjiW48y1v1GEHlSgfKfNZEKMMr5ifeBzXPfETxXrVx8P/ABP4c8X6HHpetS6PcS29xBcrJa3/AJUatN5OSHBAJbYQTtDHJ2k0AdP8Gp5VvfHumzIVNp4ku5EJIOUmIlH/AKGfz9c1zulO3/C2r2LeSi+L1cJngE6HPk498D8q3dZi13wXq2reLdFshr2kalBFc6nYeYsdzA8UaJ50DYxIDEvMTEHcoKt8xFc5Y6InjWw8W6v4dks7m+h8SWmtaTLIzCN5I7S1kQOVIOGR3Qg/dLnuKAF+xk/H1dRil2NFr72kqKxBdJdEjcBuzANb556H9LPinURaftPeGBPIqwHRWhG4jHmSyyBQOep8v3+6azvDVnqnjXUfFHijw7cDTdT+16Xq2mpcqJIPNOlxhoZeMlWjuGQlcEZDDpg05L+X4heKbXxB4es4n1WHQdO1i1tZJNo8+C7ulltTIyjH3pE3YA3KpPy5BAJfGlzLY/Gw3cVu86R6zoEUm1tuxZYr+DcTjoDKvHfp3r3+vEdKhHxH1XxdeaVdT6XLf6do97ZSyRDzbS4gnuiokRgQSssJBHQgcdQa6m08eaho1n4itPGllax67o2nS6sosHPk39ou/DxhiWRgU2srE4LKcndgAE3x2kMPwx1GVRkx3Nk/5XcJqH4LhYofGluqBfI8UagDgY+8yyD9HA/CuK8feKNdvfh7rPh7xto8Wm+JBHa30X2NjJbXUAu4d5RucPGWVXQnPRlyrcdfm9+H/jO8mkhe78K+JdQjdpk+/p17Jsi+cd4pGEYDfwtwRyCQDE+BMqJr+t27uBO1qWCnGSF1bVQTxxwWH517NXgngaCbw78P9H8eWunq82lQ6lbaraFPLmktDevJIVLMMPEUZwjdQXXgsCPdrS5gvLSG6s5op7aZFkilicMkiEZDKRwQQQQRQBLRRRQAUUUUAFFFFABXgHiPym8f39lL4Vhm8Vza7ay2Fw+hxSQvYgxb3afZnhRKSxbcCoAxivf6KACiiigAooooA5Xxl/yMfgT/ALDUn/puvK6quf0vwV4V0i/ivtK8NaJY3sWfLuLawiikTIIOGVQRkEj6E10FAFJ9J099Zj1ZrK3OqRwm2W7MY80RE7im7rtzzj6+prmPiB8PdO8aT2Mt5cT2xiHkXIhwPtlqZEke3c/e2lo05BBHP9412lFAHK/Ebw5deItHszpU0MOsaZfQ6lYPcFhEZoyflk287GRnU46bs84qLwn4Ni034df8Ixq3l3MdzHcrdrEWVG+0O7yIrfe2jzCobgkAHg119FAHB/A7RtZ8P/DDR9N8TxSRa1G1zJciSVZWLPcSPkupIJIcHOT19a1PFngfR/FWqaXfass7NYbh5Ucm2O5RijeXMMfOgeONwP7yj3B6iigCnrGm2usaTfabqEZks72B7adAxUtG6lWGRyOCelc/4H8Ht4f8O3GnazqUviC6vG3311eRD/ST5SQgMvPHlRopySWIJJJJrrKKAPOfgV4N1TwV4NudP1+4+030t7I24tuHlIqQQgHJ+XyoUIB5AIBwRiq+i+D7rTfj/rXiSOxjh0q/0dYlni2gPP5ilw4678KDnGCO+c16dRQAUEA9aKKAOSl+H+hzeOG8UzpcSX5McnkNMfs/nRoUSfy+hkCMVDHOB0wea5742+HLjWbnwJe2FhLdz2HiOza4aIEmO0ZwZSwHVNyRE8cbQeACa9OooAqaxp1vq+k3um3yF7S8ge3mUHG5HUqw/ImvOv2cNL1HR/hhb2es2l5a3q3lyzreRlJWzKSGIPJz1z3r1Cge9AHn/wAXPALeOYdEEEywtaXgW73Sunn2EhH2iD5eMttjIJHBQYK9a5z9qfSr3UvhtbNp8yQfZ9TgM8jOVAjlV7Y9OoPngEccE/SvY6juLeG5jEdzFHLGGVwsihhuVgynB7hgCD2IBoAcI0EXl7R5eNu3HGPSvJv2cdOOkaH4usDaG08jxNeIIdmwIu2PbtH93btxjjGK9boIyMHpQB5L+z3pUejp8QLWGAW0MXiq8jhgVQFSILGYwo7Dawx7Yqx8N/DWq6T8T/G9zqMLtpwZV026aMIJUnmlupUHJzskmK7u/t0rutd8TaNoN5pVprGoQWt1qtwLWyicndPIewA7cgZPALKM5YZl1rXdN0R9OXVLpbdtQuksrUFSfMmcEqnAOM4PJwPegDyn4FabDpHxD+KOn2xcwW19AsO5iRHG3nS+Wo7ANI//AH1Xc+PvA1r4yuNHe7uPKispwbiFollS8t/MjlaBg3AVpIICTgnCEdGNZXxq8Uah4Q8MRXHh2OJNTuLhpd7oGTy4InuJt69W3RQOnBU5YfMuM16LQB5F+0P4bvdYsPDl9pNvqFzdW2ox288FmpYSWsro0ocAZC5hiOegxz147n4kaG3iXwD4g0aOK3lmvLKWKFbgZQS7T5bHrghgpB7EA9q6SigDi/hFa7/hR4bF8ftT3unpdXDSjd5rTjzXLZ65LnOeuTXX2ltBZ2sNrZwxQW0KLHFFEgRI0UYCqBwAAAABVePVLJ9Zn0lZ1Oow28d08OCCInZ1Vs9DzG446YGcZGbtABRRRQAUUUUAFFFFABRRRQAUUUUAFFcx8QV1uTSbSDwzqdrp2oy3aKGnlSIzJhi0aM8Uo3kAkfI3Cmj4a6rLrXguwvrmW7mndpo5HumiZyySuh+aJERlyp2sFGVwTyTQB09Fcrb+Lrj+19MsNS8Ma3pn9ozNbwT3L2jx+YsUkuD5U7sMrE/O3Ga5C1+N+k6lZ39zofh/xJqcdqTKpgsiomthvDXCsxA2ho3UKSGJGAOG2gHrNFVNJ1C31bSrPUbFzJaXkKXELkEbkdQynB5HBFWlIYAqQQeQRQAtFYekeK9E1jxBq+iadqEU+qaSUF5AoP7vcMjnGG9DgnaeDg1p31/aWCwtfXUFsJpUgiMsgTfIxwqLnqxPAA5NAFmivFvixc67efF3wZZ+DreO41rTLC/vZIriYRxRxzBbaOZ+7KrksVAyQpA5Ndv8MdY1LUNO1XTfEEkk2s6LqM1hcXDwrF9pUYeKYKvA3RPGcDHOeOlAHZUV5To3xabX/iNpOi6Ro9wPD1411CusXKMkd1LCpOLcjIYAo+ckZwemMH1UkDGSBnjmgBahvLqCys57q8mSC2gRpZZZG2qigZLE9gAKw/HHiqHwnpEd3JYX+o3NxMLa0srCEyzXEpVm2qB0wqOxJwAFPU4B5Dx74ig8Tfs/a3rtjFJFBfaNM6xyY3plcFTjIyDkfhQB1Pw88a6d470SXVNJgvYIY5zA0d5EI3zsV1bAJ+VkkRgc8hhXUV4p4ps/GHhvxdENCtrax8KT6/pl3LexXIDPEy21ibPyduewfP3duOdwxXqvivxDpvhTw/d61rczQafahTLIsbSEbmCj5VBJ5YD/AOtQBrUVHbTx3NvFPA26KVA6NgjIIyDzUgOelAEMN1bzTzwQzxSTQECaNXBaMkZAYdRkEEZ7V5t8TfGet+HfG3h+10WAXVmtnd3+pWgUNJPBH5YxFxuMoycLwDnn1Hnt9a6p4fi8Q/Em08RzWulz6wgv4kXzZLpYdWmtwCzfcjW3ZFCr1284A+b0PUD5n7RVkoODB4Vnl6Zzm5RePyoA6nwF4mm8T6Vcy3+lT6PqdlctaXljM4kMMoVXADjhgUkRgR610teb/DbUWPxI+J2jlVC22o2t4G7nzrVBj/yCPzrK+GvivxDr/juK81GYjQdd0m4v9Ps3tTEbeOG7EcRJ3MGZ4pldiPVR0AyAaeofFmzttXFpFoGttZJqa6ZNq00SxWUbecYXbzMkna4K4IH1A5qr8ZfiBq/gzW/DkGjWUF5FLBf6hexyyGPfBbW5coH2ttJzkHHVVHAJrkPE9iLz4HfECQRs8ln4jv71AoycxXxY8f7oI+ld54o0208RfFDw9DMyyWr+H9TbgbhIsjW0Z/DbIaAOd+LOr/ak8O+I9MtZbq3g0eTWxDkI7QQ3+lXL9TgERoxx7d6j+MM9t4nvvB/2d2uNMvtH1TUoNvBLpBDJBKh6o6lshhyMkdGIq74Q0+DVtJ+HOnXa7ra88C3VvKvqjrpykfkawvDtuNQt/g3bHIEvhi/jIBwTm3tl4PrzQBo67b3HjTwJ8MbWe8/0vWrKaGS6cbiJJtHuVZyB1OWJIrqvhh4l1rU9d8WaH4qktH1jSZbSR1tIjHDEk9rG/lrkkttdZfmLEnOcKMKOE+Fl1LP4P+CHmv5n+lXi7j1AS1u1UfQDj8K9J0Kyitfi34vmiB33el6XPJ7sHvI/5ItAHSaNrWna0t42l3cdyLO6ksrjZnMU0Zw6MD0I4/Ag9CK8p8B/E3xV4i1vw8l9oen2uiX97eWLXwkO66eNZ3RoE3ZCKIAGZs7mb5QMGqvwE1hjN4rVTG8WsSP4ot5o33BBO7xvGV7FZIGxgnIIzg8VieFJ5NH+HvwPnZCjHV/s7CYYP7+O4T/2c4/CgCz4nuZ7P4w+LPEdlqD21xok+g2Ux2q4ks7mUie3+Y7VDFo33YJBTgjcTX0FXgvi/TnuY/jy5BaFILOePcoIWWGySXIz1I2ofyr3qgAooooAKKKKACiiigAopGYKpZiAoGSTwAK820v4yeHtR1y3sksdchsLqYW9rrE9iUsbiQnChJc/xHABIAOaAPSqKKKAKOs6Rput2f2TWtOs9RtdwfybuBZU3DodrAjPJ5qzaW0FnbRW1pDFBbxKEjiiQKqKOgAHAFUfEGu6f4ftIrjVJpI0llWCJIoXmklkOSESNAzMcAnAB4BPQVNo2qWetaZBqGmTie0nBKSAFc4JBBBAIIIIIIBBBBoAwvGX/Ix+BP8AsNSf+m68rE+H9rJqPwC0WzQlpbjw+kK5OeWg2gVs+Nm2a/4GbjjWJTycD/kHXveovg2oX4T+DwP+gVbH/wAhrQByvhvX5p/2Xk1axeS2urbw1KscithllhgZN4I6HcmR6V0/wznGn+GbvRLqOS3Hhm5fS98zKd8EaK8Em4E5Jt5IS33fm3DaoAFeS6lqMlj+y14o0+0y2pWN/daTcxFeUkkvyCvoT5cynI9RXY6prF3p8vxttxA0TWlmmq28xP8ArN+niPj6NanmgDK8CfaTr3wtv7wxPd6xYazqc5hUqiG5khudigknCmXHJPr3rJ+LGtX1/L4i8UzqX0PwPqtgljZjaPPu0nhaaUvjcMJL5e0/Lzu6itnTkk0fxN8CLKUqzf2PeWjsuSNwtIG4/FKzL+BNT+E3xrR8hf7a1GUHPeFIT290oA9AsrBf+F96je4+aHw1bxDn/npd3DH/ANFis3Tdal07xP8AGR4iobT/ALPeoSOjf2enX2/dCuq03/kqfiH/ALAumf8Ao+/rgvE1v9j8S/GMiPyvtvhmC6BDE+bthuY9/sRsC4/2c0AZXguzSw0n4DzXbKsh+0kSO2M+fZyuBknqxK/U9Ky/2n9Uvn1ma3gS4WLw9o0Ou2s0Mki7Lt9QhiV2AO0lY1l25Bxvc/Tp/F1oV8C/CG4t1Km01jRxkDOEdBGR/wCPD9Kt/FGxgupfidLKp8yLwZBtYHoN9++PxKL+VAGtfmTUf2hNMtpreKS10nw7LeRSPGrFJp7hY8qSMqdsJGQehI7nPAwXKW/7H1w5c+UmmT2uPRvPaPH58V6rYAf8Lg1045GhaeM/9vF7XiviMPYfs8ePtMtWeOKz8TT2VvGpIIj+3RkKO/O49c9aAPZfjTaPefCrxK0NxLaz2dqdQhljA3LJbETp1/2ogPoapeLJW8Wa74M0mzvo4tEvo212fECyNdJbS20kUWScKjNKGJAJOwAYBNd7LDFdW0sFxGk0EoaOSOQBldTkEEHggjjFeG/BVtRvvH0FrdTW+zwf4cHh+7gjZiEuhdOgdNyjIeK0R8+jL74AN/4B39wnwccOAsunT3sCKFACBJXIX0wM4/Cuf+A+mal4d17RIF1TULzRfEXhhdbkivJfMEV75kRl8rgBVIuASOSScknArZ8F6lDp3gj4p3M7lI7DXNYeQkdOPM49eGH51Z+HzrDL8KY5SFd/B86KD3YDTjj8gfyoA4N4Ztf/AGM9ReAfPJ9pvCD/AHU1F5W/8dU16Fbv5/x8jmbG5vB4Oc5A3XWT9egrnfBNotl+yBcRJIZA3h7UJskYwXWZyPwLY/Cuh0AZ+NNmP+pOg/8ASk0AX9Hih0n4qfEO/jRmaXTNNu5VHVmUXScf8BjWs34cAZ+Fh7nwZN/7jqo+MtXi0/xr8QrSdXL3Hgpb8RqOWSFrpWwexzKBil8IXT6fqXwZtW2hrnwvc2zA+0Nk/H/fv+dAEmjW4vfhH8R48fJc32vbSR2MswBxU3gGY3Gu/DqViC8ngqRz+LWJpvw/lS9+Dvii5hjaKG6utYljV/vBWnmxn3HT8KrfDOQtr3w4j2YVfAe4N65az4/DH60AT/Cy5iu4vhdLASVHhC6iORj5kfT0b9VNc/8ADi5+03vwUURspj8P32SRwcJAvB9flz+Iqv8As63ElxD4AMwIdPDmqR4xgALqECjj1wtV/g1Cba8+FdpKztc2tlrsMhc5O1bpUH4fKQB2oAs/DQi30r4OWaL8ianrChs9AiXagfr+ler6cwHxV8QLzk6Lpp6cf6++71454FlRdY+DMPIdtQ8RsMdMBpwf/QhXpKzXUP7RMkPIs7rwqrnngyRXbDp7Cf8AWgDyr4YzjTdLNvGrxyt8Olu1ZgRjFxckn8TICPautGmxy/BT4UyS5L2l/oVzHwOGaWNf5SGuVsreSyg8K325/LvvhrPa5B7xRpJyO+PMruogf+FIfDb/AK6+Hv8A0fbUAR+IXY6T8d0IOwW7EHHc6VFn+Qr1+GRJoUliYNG6hlYdwehrynxIG/4Rf44Eg7dk2D2z/ZFvn+ld94HuxqHgrw/eAki40+3mBJzndGp6/jQBt0UUUAFFFFABRRRQAyeFLiCSGVd0cilGGcZBGDXg2taBc+D49E0fxp48gXwPbXERs7MaeftMywFXjjkdAcIhVdz8cAZxni7J4n18fHj+yf7bVtLivli+yqMxlZbVn2OQnDKYcj5vvSehxUNl4l8eax8RbXTtS8JaAL7S40lklTUXxHb3BKPgdHJEZ+Ug8qKAPZNC1mx120kutLnE9vHNJAZF6FkYqcHuMjgjg1o1k+GfD2meGNMOn6JbC1s/OkmESklVZ2LEDPQZPAHAHFa1AHMeNdF1DUbjQdR0X7I9/pF6bpILuRo4plaGSJlLqrFTiTIO08jpzxN4A0K48O+F4LC9likuzNcXMxiJKB5pnlZVzg4BfAOBnGcDNdDRQB5B8T9BsfDkGjahZzaxNIk178l1q91dKQNLvW4WWRlDfKPmAz155Ndn8JoXt/hb4Rik4ddJtcj0PlLxXO/HyXyPDmnS7inlyX7bgASMaTfnODx+ddr4LhFv4P0KBBhY7CBAMYwBGooA8cmjtLix8eaNIwzL4609powcHZNNZ8/jtf8AKt/4lXtvHqPxNsXlUXc3gdZ44+7Ihvw7fgZEH/AhWd4v01x8f9Dsp7QjT9de21A3EJUEy6elw4RwBnG6SA7yf4AvIJ23/jTbW8N/q16cLPP4I1uBmOBkK1sVGfrI350AaPxI06307Wfhfc26hZrLWk0+FvSKS2lDL+Plr+Vcn4aga8+CXxPeNCoubvXJI1HUfewD+IrtPjNJ5MvgGU52r4qslOP9tJUH6sKofBawM3wr1OGaIhby+1MdeXBnkQn26EfhQBqfD7VP7c8U3OqjIF74a0a4APUb3vHwff5q534lziPxB8Rog2JW8B+YvPOFe8z/AOhCk+Abh7yVQjLs8LeHhk/xfuZzkfnj8K5z9oG3vrDxV4h1WEYgvPBE1hGcglmF7CJFx/u3C/n7UAdX8RFng/Z9sr+xJW50q10/UYsesDRSfyU07x/Ok0vxbjVlzD4QgjbnOCV1BufThhXQ/FSzW0+C/iezh+5b6LPGvHZYiP6VyvgWFfF3ib4oXEqBbTWbPTbdRwyhHsAxXcPvf6707/kAanw111fEfjnU9R3hnk8OaPIwCkYMn2mXH/kQH8a4HV0OoeDPGulKcTS+P47cLxk+ZcW5BwfqfyrU/Zqmkm13xEsmdkOh+HIk+n2AsR+bH86paxH/AGf408T2SF1ifxroN0AeQxlMTNj8VP5CgD6FAxn0rD0fwvp+k+JvEGu2/mtqGttA1yztlQIYxGiqOwxk+pLHtgDdooA+fvFa/ZtL+PloCRCFhuFXtuktELEe5I/Suq8RW0+lfFH4QW1u/l28dvqNlKinAZRaoyrj0zED+ArjfHjapqHxD+IPgnR9Ma51HxNaWMkc0kywxW1ssflyTMTy+1io2qCT83cYr1XxtaI/jT4e3hUeZFqlxED3AewuSR/44PyoA5TSrRrX9lFoThmfwnNIAo/v2zOPx+am+ALoX3xM0G7UqVn8C2ko29OZs10PhSxbU/gDo9gisz3XhiGAKhwSWtQuAfXmuD+CM0k3jHw0XYuB4Bsxk9sXLj+Q/SgDX+MenpFr+u6iB+9uPAesW7HjlY3hYD1/5amtTxToktt8QvhFeLHHHbae97YMiN91pLFioA9MQtz9Kz/jrfQWV5JFcPte+8I6/bQDGd0gjt5CPb5I3P4V2njf/kYPAf8A2G3/APTfeUAcZ+zpA2pfASzR3y96b0F2JJJaaUZPqa5T9n/UW1HxJ4L3sxeHwVNGRkkKq3yxqfqREfyrt/2Xo3j+BvhzzAQW+0MM9wbiQg1yX7O9pGniRGQoq22hyQRoFAwp1a96egHlqMUAN+BDTxeKPDllM4Ig0PWDtAxhjq4DHB5Gdo6+lXvBkSW/xM8LW8bEiI+JFAJyQBqTAE/l+lTfDqZH+MphVH8yLT9cdnK/KQ2uSBQD6/I2fqKh8HqG+L2iHPzKPEZ/D+1HA+nOaAOd8GSp/wAJ78MbL5hLYa14ntmyeHPzMSP++1H517HrQjtfilo97hBINA1IMzHAwk9kRk+nzH868X8KAp8afC0BJ2weKPFCJxzgwxtz6/ePNd78ctTfTNVtjGUDz+GNfjAbuVit5OP+/f5ZoA5HUn2eDPhvz18DaoOuM/6HbH+ldD48m/s39mDS7pULvYWGkXAUHbnZJAf6Gsr4maNcaJF8OdNCb47Pw/q+myyDkAjThjB9zEfwBrpPG1mt9+zHdRugcL4dhlweOY4lcHPttB/CgDobDThqsnxNsCyr9r1DyCWGRhtLtF59ua0vhP8A8ks8G/8AYFsv/RCUng4BvEPjwEAg6zGCD/2DrOpvhjbz2fw28J213DLb3MGk2kUsMqFHjdYVDKynkEEEEGgDpaKKKACiiigArifiN46l8Iz6ba2GhXet396s0wgt5Fj2QxbfMcs3pvXA75rtq5Px38O/DHjxrI+KtNN6bLeIMXEkWzft3fcYZztXr6UAZugeEvDeva1YePrIXpkv4I72OB5iId7xbVlMfQSbGx1xznGea5eP4U/BzQ9ftVMOn2mrQSxyQwy6xIJA4IKfI0uTzjjHNeheBvBHh/wNY3Fn4XsDZW9xL50imaSXc2AM5diRwBXz9qF7pNv8bddivLjwfZ3Da3Dsh1LS5Ly6kJSL5o5QCEyegyMNk0AfUtFFFABRRRQB4h8cLnxHN4ZhXXNK0iztgmpFZLPU5Lly/wDZF/gFWt4wBjPO49Bxzke0WC7bG3XriNR+leX/ALR8iReDLVpXVFLagoLHAydJvwB9SSAPrXUwfETwRHBGh8ZeG8qoH/IUg9P96gDrq5fx14OtfF/9hLeTtEml6nDqW1UDed5ef3TZ/hJKk9fu/iG/8LH8D/8AQ5eG/wDwaQf/ABVH/Cx/A/8A0OXhv/waQf8AxVAFP4waPdav4N3aZYvqGp6fe2uoWtsjqhleKZWK7m4GV3DPbPfobPw00e90LwDZWeqhEv28+6uI0ORFJNK8zR5yc7TIVznnbmn/APCx/A//AEOXhv8A8GkH/wAVSN8RfA5BB8ZeG8H/AKikH/xVAHAfs420h/ta+ZFWNtL0O0VgD8xj06OQ57Z/fjp2xU3xysrjUvG/w+0xJJIbLVJrmxvJFi3Dy91vPtDYwrE24weuAx7Gsr4B+M/C+j6L4isdS8T6NbC21drS2N1qMKma3gtreCORSSNysIuCOK9O/wCFjeB/+hy8Nf8Ag0g/+KoA6PULODULC5sruJJba5iaGWN1DK6MCCCD1BBPFcV8HfCWqeD9BvbLXJrGe4e4jWKS0DANBDbQW0RYNyHKwbiASAWOK0/+Fj+B/wDocvDf/g0g/wDiqP8AhY/gf/ocvDf/AINIP/iqAOJ/Zwttujald7v9Zb6TDjHTZpVoc/8AkT9KxfEmnrqHxjMLK20+J9KmOM8mHT55V/IqD+FWPgl4r8MaFYeKYNR8U6DbwPr1wunrLqkAJsokjggwN33QkQAz1AB6EE5ep+KvDUP7RukaknirR5dCuLF53dL+IwxXiRvEGdg2AxiYqM9c0AfQ1Fcr/wALH8D/APQ5eG//AAaQf/FUf8LH8D/9Dl4b/wDBpB/8VQBrf2Bpv/CUf8JF9m/4nH2P7B9o8xv9Rv8AM2bc7fvc5xn3xWP40YJ4h8CFjgf21IPxOn3gp3/Cx/A//Q5eG/8AwaQf/FVwfxf8eeEJdK8P31p4s0aZ9M16xvXFnfpLKIhJslISMlmHlu+QAcjNAHefCf8A5JZ4N/7Atl/6ISvLvgK4l8VaYq8/ZvBWmRH2LO78f99V1fwy8feD7P4beE7W78WeH4LmDSbSOWKXUoVeN1hQFWUtkEEEEGvN/wBnnxh4bhv72+1jXtI0/wCz6NpmlwrdXkcJYxxMZMbyCcMRnHGaAOr/AGqZ7fTfCmlapcE5WS9sEwCebnT7mMf+Pba674r3407Uvh9Oej+JoYPvbf8AWW9xH1/4H079Kw/iTq/grxhB4dSPx14Wi/snW7TVWSXUYGWZIiQ8f3+MqxI4PIA4zkVvit4r8HazY+HJLfxd4elfTfEOm3+xNQhdionVHPDcBVdmJ6AKaANn9m2Brf4I+FkfOTDK/Po00jD+dc7+z0oOoaiSi749PRCSPmXOp6mcfjgH8BVz4J+OfCGm/CjwxZ33ijQrS6hs1WWCfUYUdGycgqWyPxri/gH4k8O6B45+Jh1TxNodvbz6gn2SR76NI5o/MuH3RszYYfvOcdPxoA3vhsqj463DDy97aVrAPzHdga7PjjsOTz359DU3w1lz8ZtStD5wmtI9VZlMeFCS6kXViffnGOoFcp8N/GfhyH446neXGt6Vb2C6dqVuLq4uo0jZ21eaZQjkgENHKrD17dK2/Bfi7wtZ/H/4g6jJ4j0OLTby1svJuXvoljkYRqGCMWw2CDnB4PWgBPBll5vxqhYKrC11vxDNllyRujshkeh/eYz6HHetX9qPfaaHoeoQRCa5llu9Hjjxyxu7OaMAcHncqenvxXP+DvGPhu3+Ld3dz+IdGiszf6w3nyXsaoVkTT9hDbsEMY3we+xvQ10vxb8SeGvEX/CGf2T4r8Mzf2b4lstRuc6xbJsgj3725cZxuHA5oA2fjsqLYeHZim6QXtzEDnBw+nXYI/Qce1N17B/Zou2Axu8LZ/8AJUVyX7Rnjzw3ceBIJtB8S6Re6ja3nmRQ2l3FOx3QTRHKqxO3Ehya6ObxV4MvvhC2gyeLPDwmm0P7EYzqkAYMYNmOW4OaAOx8G/8AIx+O/wDsNR/+m6zrqhXjPwj+I/hqWw1i+1rxLolneX1xaXLx3GoRI246bZh/vMCcOrqf9pWHUGvU9D1/R9fill0LVtP1OOJtsj2dykwQnnBKk4NAGnRRRQAUUUUAFFFFABXj2sr42Hiu+0m107U2F3rNtfWutR3Y+zW9mvl74mQnjhZFKY+YsDzxXsNFABWVL4h0tdTuNLgv7O41qGIynTYrmP7SRtyPkLAjIIwTgcjkDmtWo7iNpbeSNJXhd1KiWMKWQkfeG4EZHXkEeoNAHCWfxBur/wAOaJd2ehgavq+o3OnQWFxdhFjaF5g7SSqrAALAx+VW5IAz1rpPBuvL4l8PwakIDbSNJLBLDv3+XLFI0bqGwMjchwcDIwcCsGy+HNtaaLbWCa7rTSWl9JqNpeE24mtppDIZNuIQhVvNkyHVh82BjAx03hrRLbw9osGmWLSvDEXcvMwZ5Hdy7uxAAyzMxOABzwBQBy/xV0xdbbwxpUjiNL6/ubVnK7gofTL5c479eld3XnWseE/Dmg+LfA91oegaRpty+rSxtLZ2ccLsh0+8JUlVBxkA49hXotABRRRQAUUUUAcr4A8I/wDCJf8ACR/6d9r/ALY1m51f/VeX5Pnbf3f3juxt+9xnPQV1VFFABRRRQAVlX3h7Sr7XtM1q6s0fVNNEi2txuYNGJF2uODggjsc47YrVooAKKKKACvO/2hNGv/EHwd8R6dpFtJdX0kcUkcMalnfZNHIwUDknapwB1PFeiUUAIqhVCqAFAwABwBXjn7PlqLLXPiVbDG2HxBJGnAHyAYUflivZK47wD4Pm8L6t4svJryK5Gt6m9+gSMoYlYfcOSckevH9AAdjXI/FKaO38LW808ixwx6vpTu7nAVRqFuSSewxXXVxPxstpLn4T+KPIfy5reya8R/7rQ4lB/NKAG/A9Cnwh8IhiSTp0JyRjgrmuf+FoA+Mfxa2gAfadPPAx/wAsGrqPg4hT4T+Dwcj/AIlNs3PvEp/rV/QfCVjonifxFrtpLdNda68D3McjKY0MSFF2AAEZB5yT7YoA8m+HVlFZ/tR+P0Rmc/YhMMsT5ZlMDMuMd8KRzwMe+PY7fw9YW/im68QRRsuo3VrHaTMCArojMykjHLfNjPoAO1ec+AYfM/aI+KVwyljDBpkSuW+4GtwxUD3K5/D3r12gDwr4ezbP2h/FFhIV82MahdhcchJf7OCn8fLb8jXuteP6TblP2p9cmLJhvDUWFzyQZkHT/gP6ivYKAPMv2k7Nb34LeI42heZ1WJ41QZbeJkwR/npmvRbC2Nrp9valxIYoljLbQobAAzgdPpVigADoKAPEv2StRfVfh1qF1IrL/wATBYFDdlis7WIAe2EwPpzk817bXEfCXw6fDeiaxAbT7Gtzrd/dRw4wBEZ2EeB2BRUI9sV29ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHmHivxppc2veDJEtfEAWDVpJHD6BfISPsN2vygwgucsOFycZOMAkdL/wAJ5pH/AD5+JP8AwnNR/wDjFaus6R/aWo6Fdef5X9l3rXm3Znzc280O3OeP9duzz93GOcjVoA5X/hPNI/58/En/AITmo/8Axij/AITzSP8Anz8Sf+E5qP8A8YrqqKAOV/4TzSP+fPxJ/wCE5qP/AMYo/wCE80j/AJ8/En/hOaj/APGK6qigDlf+E80j/nz8Sf8AhOaj/wDGKP8AhPNI/wCfPxJ/4Tmo/wDxiuqooA5X/hPNI/58/En/AITmo/8Axij/AITzSP8Anz8Sf+E5qP8A8YrqqKAOPm+IugwSQRzxeII5LhzHCr+HtQBkcKzbVBg5O1WbA7KT2NTf8J5pH/Pn4k/8JzUf/jFaus6R/aWo6Fdef5X9l3rXm3Znzc280O3OeP8AXbs8/dxjnI1aAOV/4TzSP+fPxJ/4Tmo//GKP+E80j/nz8Sf+E5qP/wAYrqqKAOV/4TzSP+fPxJ/4Tmo//GKP+E80j/nz8Sf+E5qP/wAYrqqKAOV/4TzSP+fPxJ/4Tmo//GKP+E80j/nz8Sf+E5qP/wAYrqqKAOV/4TzSP+fPxJ/4Tmo//GKzvEXifQ9d8P6npFxbeJ44L+1ltZHTw5qG5VkQqSMwYzg13dFAHA+HvGHhnRdNsvD9hF4kYaZZwxLE+gag0qxAFI2YeRnny2GcAEq2OhrU/wCE80j/AJ8/En/hOaj/APGK1bbSPJ8VajrPn7vtdlbWfk7MbPJed927POfPxjHG3qc8atAHlui6rpOmePvE2vpa+IPJ1m3slZR4d1LeJYBKrEjyMY2tFjB7HgdT1H/CeaR/z5+JP/Cc1H/4xXVUUAeK22qRx/HS98TvYa+dHl0JLFZB4f1Df5wnD7dvkZxgZz05Hvj0D/hPNI/58/En/hOaj/8AGK6qigDlf+E80j/nz8Sf+E5qP/xij/hPNI/58/En/hOaj/8AGK6qigDlf+E80j/nz8Sf+E5qP/xij/hPNI/58/En/hOaj/8AGK6qigDn9G8XaVq+qrptsNShvWhe4WO90u6tN8aMisVM0ahsGRAQDn5hXQVlXOked4q07WfP2/ZLK5s/J2Z3+c8D7t2eMeRjGOd3UY51aACiiigAooooAKKKKACiiigAooooA8X+Juj3N34o1p20i9vdTntrFfD95FaPMlpKsrGQiRRiAglWZmK7l4ycYr2iiigAooooAKKKKACiiigAooooA8JhspZPDfjewsdM8QSWk3iK3vpIbq0uxLeWH+iidUeZd0hIjmGzJJAwBgjPe/Ceyazste+z2M2n6PNqskumWsts1sY4PKiBxEwBjUyCUhSo65xzXc0UAFFFFABRRRQAUUUUAFcz8R5LGPwldHU9Eu9dtt0f/EvtoHmaZgwKhkUElAQC3BGAeD0PTUUAfP66FaR6fpA1HRdS1PQFh1Mmwi0W6EVpfStE8Qjt3jDiNVMiJJtwCScrnA9l8D2+oWvgrQLfWmZtUisII7os25jKI1D5Pc5zz3rbooAKKKKACiiigAooooAKwfG7Wf8Awjlwmp6U2q2khVHtxYG+UZPDtAOXVTgkLk8cVvUUAfO9loTR2Fh/b/hvUL3w8n9rCC1i0qXYtxJJGYJVswpeBNglVAwOw8kjdmvbfA9vqFr4K0C31pmbVIrCCO6LNuYyiNQ+T3Oc89626KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDzPxj4j8WaZ8SvDPh3Tb3Qls9eF20clxpssklsIIg+Di4USbs46Lj3pll8VbaO6ms7q1vdRvX1660S2js7SODLwqrYJkuCD1+/lc/wB1e/dah4e0vUNe0nWry28zU9KEos5vMYeUJVCv8oODkADkHHbFZcPgDwzDqEd7HpuLqPUpdXV/Pl4upQA8mN2OQB8v3R2AoA5bTvjh4Yu7W2u57bVbKyurG4v4bi4ij2yLASsqAI7NvBBGCMHsTWz8O/ifoXj28vbTSFuIrm1ijnZJmifdG/QhopHAI6FSQwJwQKms/hh4OtLawtodFjNvYwXFtBHJNLIqxTkmVSGY7txY/ezjtitjw54X03w4pTSjqCxeWsSxXGo3FxHGq9AiSyMqAdPlA44oA4vTPHU0J8f+JdauZv8AhHdCvW06Cxt4FdwYQvmSk43EszgD5goA59abc/G3w1baLY6jcRXCC+na3toRd2TlyqqzMZFuDEgAZQQ7q2SBjkV0On+CI7PVvEsi6hcrpOuTJdyWcDyW8kNwAA8iTxurAPtXIGOnXBIpifDHwklsIk0yVZBdtfC6W9nF157DDP8AaN/m5I4PzUAZnh/4t6P4mksovC+maxq89zafbHjgSGM28fmGP94ZZUXO5WGFLHjPShfi9oB1FIDa6mtlLezabDqJjj+zzXMYy0a/Pv56BigUnvW3L4A8PyXVtdmPUlvreIwLeJqt2lw8e8vseUSh5FyTgOTjoOKanw58Kpq76kulf6Q80lztNxKYVmkXa8qw7vLVyP4goPvQBzul/Gvw3ewRXFzZ6vp9rNpkurQzXUMZWWGNirgbHYhgQeCBn8RXOW3xhltfFXiHUdZttVtvDNro9pfW9g8EDT5lYAPlGIAYEffcAd8V6FB8NPCMFvZwJoyGG0spdOhR5pXVbeQkuhDMc5JPJyR2Ipmn/DPwxpzSvYW+pW8skEds00er3iy+VGcogfzdwUegIGOOlAHO+J/H903hrRPFugytFpcWqxWl/ZtLa3IuIZGEZIkheQBlZlIw46EMK9Vrgb74Y6U9ppGm6YwsdDtdSGq3lptaZ76ZeV3yu5ONwBbO4tgDIrvqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Recordings of tidal volume, flow, airway pressure (P",
"    <sub>",
"     aw",
"    </sub>",
"    ), and esophageal pressure (P",
"    <sub>",
"     es",
"    </sub>",
"    ) in a patient with chronic obstructive pulmonary disease receiving pressure support ventilation. Approximately half of the patient's inspiratory efforts do not succeed in triggering the ventilator. Triggering occurred only when the patient generated a P",
"    <sub>",
"     es",
"    </sub>",
"    &le;8 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O (indicated by the horizontal line), which was equal in magnitude to the opposing elastic recoil pressure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tobin MJ, Jubran A, Schweiz Med Wochenschr 1994; 124:2139.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12178=[""].join("\n");
var outline_f11_57_12178=null;
var title_f11_57_12179="Patient information: Depression (The Basics)";
var content_f11_57_12179=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15342\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/44/40640\">",
"         Mood disorders caused by problems in the brain",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?31/32/32257\">",
"         Patient information: Generalized anxiety disorder (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/6/24675\">",
"         Patient information: Medicines for depression (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/42/8867\">",
"         Patient information: Neuropathic pain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/51/2866\">",
"         Patient information: Seasonal affective disorder (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/30/482\">",
"         Patient information: Serotonin syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/18/11554\">",
"         Patient information: When you have depression and another health problem (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?13/6/13413\">",
"         Patient information: Depression in adolescents (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/41/20116\">",
"         Patient information: Depression in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/21/29013\">",
"         Patient information: Depression treatment options for adolescents (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/24/21894\">",
"         Patient information: Depression treatment options for adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/12/13510\">",
"         Patient information: Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Depression (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/depression-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H43932596\">",
"      <span class=\"h1\">",
"       What is depression?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Depression is a brain disease that makes you sad, but it is different than normal sadness (",
"      <a class=\"graphic graphic_figure graphicRef60356 \" href=\"UTD.htm?39/44/40640\">",
"       figure 1",
"      </a>",
"      ). Depression can make it hard for you to work, study, or do everyday tasks.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932603\">",
"      <span class=\"h1\">",
"       How do I know if I am depressed?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Depressed people feel down most of the time for at least 2 weeks. They also have at least 1 of these 2 symptoms:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        They no longer enjoy or care about doing the things they used to like to do.",
"       </li>",
"       <li>",
"        They feel sad, down, hopeless, or cranky most of the day, almost every day.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Depression can also make you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Lose or gain weight",
"       </li>",
"       <li>",
"        Sleep too much or too little",
"       </li>",
"       <li>",
"        Feel tired or like you have no energy",
"       </li>",
"       <li>",
"        Feel guilty or like you are worth nothing",
"       </li>",
"       <li>",
"        Forget things or feel confused",
"       </li>",
"       <li>",
"        Think about death or suicide",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you think you might be depressed, see your doctor or nurse. Only someone trained in mental health can tell for sure if you are depressed.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932610\">",
"      <span class=\"h1\">",
"       See someone right away if you want to hurt or kill yourself!",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you ever feel like you might hurt yourself or someone else, do one of these things:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Call your doctor or nurse and tell them it is urgent",
"       </li>",
"       <li>",
"        Call 9-1-1",
"       </li>",
"       <li>",
"        Go to the emergency room at your local hospital",
"       </li>",
"       <li>",
"        Call the National Suicide Prevention Lifeline:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        1-800-273-8255",
"       </li>",
"       <li>",
"        www.suicidepreventionlifeline.org",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932617\">",
"      <span class=\"h1\">",
"       What are the treatments for depression?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People who have depression can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Take medicines that relieve depression",
"       </li>",
"       <li>",
"        See a counselor (such as a psychiatrist, psychologist, nurse, or social worker)",
"       </li>",
"       <li>",
"        Do both",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with depression that is not too severe can get better by taking medicines or talking with a counselor. People with severe depression usually need medicines to get better, and may also need to see a counselor.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932624\">",
"      <span class=\"h1\">",
"       When will I feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Both treatment options take a little while to start working.",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Many people who take",
"        <strong>",
"         medicines",
"        </strong>",
"        start to feel better within 2 weeks, but it might be 4 to 8 weeks before the medicine has its full effect.",
"       </li>",
"       <li>",
"        Many people who see a",
"        <strong>",
"         counselor",
"        </strong>",
"        start to feel better within a few weeks, but it might take 8 to 10 weeks to get the greatest benefit.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If the first treatment you try does not help you, tell your doctor or nurse, but do not give up. Some people need to try different treatments or combinations of treatments before they find an approach that works. Your doctor, nurse, or counselor can work with you to find the treatment that is right for you. He or she can also help you figure out how to cope while you search for the right treatment or are waiting for your treatment to start working.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932631\">",
"      <span class=\"h1\">",
"       How do I decide which treatment to have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You and your doctor or nurse will need to work together to choose a treatment for you. Medicines may work a little faster than counseling. But medicines can also cause side effects. Plus, some people do not like the idea of taking medicine.",
"     </p>",
"     <p>",
"      On the other hand, seeing a counselor involves talking about your feelings with a stranger. That is hard for some people.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932638\">",
"      <span class=\"h1\">",
"       Is depression the same for teenagers?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. The symptoms of depression are a little different for teenagers than they are for adults. Some teenagers are moody or sad a lot of the time. That makes it hard to tell when they are really depressed. Teenagers who are depressed often seem cranky. They get easily &ldquo;annoyed&rdquo; or &ldquo;bothered.&rdquo; They may even pick fights with people. Also, when treating a teenager, doctors and nurses usually suggest trying counseling first, before trying medicine. That's because there is a small chance that depression medicines can cause problems for some teenagers. Even so, some depressed teenagers need medicine. And most experts agree that depression medicine is safe and appropriate to use in teenagers who really need it.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932645\">",
"      <span class=\"h1\">",
"       What if I take medicine for depression and I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some depression medicines can cause problems for unborn babies. But having untreated depression during pregnancy can also cause problems. If you want to get pregnant, tell your doctor but do not stop taking your medicines. The two of you can plan the safest way for you to have your baby.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H43932652\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=see_link\">",
"       Patient information: Medicines for depression (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/32/32257?source=see_link\">",
"       Patient information: Generalized anxiety disorder (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/42/8867?source=see_link\">",
"       Patient information: Neuropathic pain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/51/2866?source=see_link\">",
"       Patient information: Seasonal affective disorder (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/18/11554?source=see_link\">",
"       Patient information: When you have depression and another health problem (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/482?source=see_link\">",
"       Patient information: Serotonin syndrome (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/6/13413?source=see_link\">",
"       Patient information: Depression in adolescents (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"       Patient information: Depression in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/21/29013?source=see_link\">",
"       Patient information: Depression treatment options for adolescents (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=see_link\">",
"       Patient information: Depression treatment options for adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/12/13510?source=see_link\">",
"       Patient information: Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?11/57/12179?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15342 Version 9.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-189.2.19.178-294E67EF58-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12179=[""].join("\n");
var outline_f11_57_12179=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932596\">",
"      What is depression?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932603\">",
"      How do I know if I am depressed?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932610\">",
"      See someone right away if you want to hurt or kill yourself!",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932617\">",
"      What are the treatments for depression?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932624\">",
"      When will I feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932631\">",
"      How do I decide which treatment to have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932638\">",
"      Is depression the same for teenagers?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932645\">",
"      What if I take medicine for depression and I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43932652\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15342\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/44/40640\">",
"      Mood disorders caused by problems in the brain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/6/13413?source=related_link\">",
"      Patient information: Depression in adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=related_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/21/29013?source=related_link\">",
"      Patient information: Depression treatment options for adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/24/21894?source=related_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/32/32257?source=related_link\">",
"      Patient information: Generalized anxiety disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=related_link\">",
"      Patient information: Medicines for depression (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/42/8867?source=related_link\">",
"      Patient information: Neuropathic pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/12/13510?source=related_link\">",
"      Patient information: Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/51/2866?source=related_link\">",
"      Patient information: Seasonal affective disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/482?source=related_link\">",
"      Patient information: Serotonin syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/18/11554?source=related_link\">",
"      Patient information: When you have depression and another health problem (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_57_12180="What's new in geriatrics";
var content_f11_57_12180=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   What's new in geriatrics",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12180/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12180/contributors\">",
"     H Nancy Sokol, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12180/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/57/12180/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    The following represent additions to UpToDate from the past six months that were considered by the editors and authors to be of particular interest. The most recent What's New entries are at the top of each subsection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     GENERAL GERIATRICS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Long-term use of postmenopausal hormone therapy",
"    </span>",
"   </p>",
"   <p>",
"    The United States Preventive Services Task Force (USPSTF) has published an updated meta-analysis of postmenopausal hormone therapy (nine trials) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/1\">",
"     1",
"    </a>",
"    ]. Results were largely based upon the two Women's Health Initiative trials, and the mean age of subjects was &gt;60 years. Estrogen plus progestin, as well as&nbsp;unopposed estrogen, decreased fracture risk but increased&nbsp;the risk for stroke, venous thromboembolic events, and gallbladder disease. Estrogen plus progestin increased risk for breast cancer, but unopposed estrogen decreased breast cancer risk. Based upon these data, the USPSTF continues to recommend against the use of both combined estrogen and progestin and unopposed estrogen for prevention of chronic conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, they note that this recommendation does not apply to women considering&nbsp;hormone therapy for relief of menopausal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=see_link&amp;anchor=H91121219#H91121219\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Discontinuing antipsychotic agents in patients with dementia",
"    </span>",
"   </p>",
"   <p>",
"    Because antipsychotic agents are associated with an increased risk of mortality in patients with dementia, it has been recommended that discontinuation of these agents should be attempted at regular intervals. One trial showed that this is not always possible. Among 180 patients with Alzheimer disease and psychosis or agitation who had initially responded to treatment with a 16 week course of risperidone, those randomly assigned to immediate drug discontinuation had an increased risk of relapse of psychosis or agitation over 16 weeks of followup (60 versus 33 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/4\">",
"     4",
"    </a>",
"    ]. Those who were assigned to drug discontinuation after an additional 16 weeks of treatment also had a higher rate of relapse over the ensuing 16 weeks compared to those who continued treatment throughout (48 versus 15 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Antipsychotic drugs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bed alarms for fall prevention in the hospital",
"    </span>",
"   </p>",
"   <p>",
"    In a cluster randomized trial in an urban community hospital involving over 27,000 patients, nursing units (matched for comparable pre-intervention fall rates) were randomly assigned to an educational intervention to increase use of bed alarms or to usual care [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/5\">",
"     5",
"    </a>",
"    ]. Despite a significant increase in alarm use by the intervention groups (64.4 versus 1.8 days per 1000 patient days), there was no difference in fall rates, number of patients who fell, or fall-related injuries between groups. Authors note that the trial may have been underpowered to detect the primary end point (falls per 1000 patient-days), but a large benefit would be unlikely. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31673?source=see_link&amp;anchor=H17785970#H17785970\">",
"     \"Prevention of falls in nursing care facilities and the hospital setting\", section on 'Restraints and alarms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     US guidelines for the prevention of falls",
"    </span>",
"   </p>",
"   <p>",
"    The U.S. Preventive Services Task Force (USPSTF) has issued guidelines for the prevention of falls in community-dwelling older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/6\">",
"     6",
"    </a>",
"    ]. The guidelines recommend against &ldquo;automatically&rdquo; performing a multifactorial risk assessment for all older community-dwelling adults, noting a small likelihood of benefit for interventions targeted to identified risks, but rather taking into consideration individual factors including prior falls, comorbid conditions, and patient values. The guidelines recommend exercise or physical therapy and vitamin D supplementation to prevent falls in adults age 65 or older who are at increased risk for falls. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/4/22602?source=see_link&amp;anchor=H21#H21\">",
"     \"Falls in older persons: Risk factors and patient evaluation\", section on 'Falls risk assessment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=see_link&amp;anchor=H2#H2\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\", section on 'Preventing falls'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     GERIATRIC CARDIOVASCULAR MEDICINE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pacemaker insertion for asymptomatic Mobitz type I second degree AV block",
"    </span>",
"   </p>",
"   <p>",
"    The optimal management of asymptomatic patients with Mobitz type I second degree AV block is controversial, with European guidelines recommending for and American guidelines against pacemaker placement. Among a cohort of 299 mostly male patients (mean age 75) with Mobitz type I AV block followed for an average of 3.3 years, 59 percent remained asymptomatic, while 41 percent required a pacemaker for symptomatic bradycardia or progression to higher grade AV block [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients who received a pacemaker had a 46 percent reduction in total mortality compared to those patients who remained asymptomatic and did not receive a pacemaker. However, because this was a single center study of mostly elderly male patients with a high mortality rate, we feel these data are insufficient to recommend pacemaker placement for all patients with Mobitz type I second degree AV block. For the majority of patients with Mobitz type I AV block and",
"    <strong>",
"     asymptomatic",
"    </strong>",
"    bradycardia, we still favor",
"    <strong>",
"     not",
"    </strong>",
"    implanting a permanent pacemaker. Exceptions include patients with infranodal AV block and some elderly patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18087?source=see_link&amp;anchor=H10101639#H10101639\">",
"     \"Second degree atrioventricular block: Mobitz type I (Wenckebach block)\", section on 'Asymptomatic patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GERIATRIC INFECTIOUS DISEASES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     2012-2013 seasonal influenza vaccine effectiveness",
"    </span>",
"   </p>",
"   <p>",
"    In a case-control study of 2697 individuals with acute respiratory illness enrolled between early December 2012 and mid-January 2013, the United States Centers for Disease Control and Prevention estimated that the effectiveness of the 2012-2013 seasonal influenza vaccines in preventing medically-attended influenza infections in all age groups was 56 percent (95% CI 47-63 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/8\">",
"     8",
"    </a>",
"    ]. Effectiveness against influenza A was 47 percent (95% CI 35-58 percent) and against influenza B was 67 percent (95% CI 51-78 percent). However, the age-stratified effectiveness estimate against H3N2 influenza A was only 9 percent for individuals &ge;65 years of age (compared with 46 to 50 percent for individuals from 18 to 64 years of age).",
"    <br/>",
"    <br/>",
"    Given the moderate overall effectiveness of the vaccine (and poor effectiveness against H3N2 influenza A in older adults), influenza infection will occur among some individuals who received the influenza vaccine. This highlights the importance of early antiviral therapy (regardless of vaccination status), particularly for those at risk for severe or complicated influenza infection.&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link&amp;anchor=H205840196#H205840196\">",
"     \"Seasonal influenza vaccination in adults\", section on 'Effectiveness for the 2012-2013 season'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=see_link\">",
"     \"Treatment of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Egg-free influenza vaccine",
"    </span>",
"   </p>",
"   <p>",
"    A trivalent inactivated influenza vaccine (Optaflu), produced using cultured mammalian cells, was approved in Europe for use in adults beginning in the 2007-2008 influenza season. This same vaccine (called Flucelvax) was approved for individuals &ge;18 years of age for the 2012-2013 season by the US Food and Drug Administration in November 2012&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef79474 \" href=\"UTD.htm?41/31/42494\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. A second egg-free vaccine (Flublok), made using an insect virus (baculovirus) expression system and recombinantDNA technology, was approved in January 2013 by the FDA for adults aged 18 to 49 years. The efficacy and rates of serious adverse events seen with&nbsp;both egg-free vaccines&nbsp;were comparable to standard available influenza vaccines. For&nbsp;patients age 18 or older with egg allergy, we recommend administration of&nbsp;an age-appropriate,&nbsp;egg-free, trivalent inactivated influenza vaccine (TIV) rather than an egg-based inactivated vaccine. However, if an egg-free vaccine is not readily available, immunization should proceed with egg-based vaccination with appropriate precautions (eg, observation for 30 minutes following vaccination in patients with mild allergic reactions to egg, and immunization supervised by an allergy specialist for patients with a history of severe egg allergic reactions). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20967?source=see_link&amp;anchor=H8#H8\">",
"     \"Influenza vaccination in individuals with egg allergy\", section on 'Alternative methods of vaccine production'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20967?source=see_link&amp;anchor=H9#H9\">",
"     \"Influenza vaccination in individuals with egg allergy\", section on 'Options for testing and administration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     GERIATRIC UROLOGY AND UROGYNECOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Ospemifene for treatment of vulvovaginal atrophy",
"    </span>",
"   </p>",
"   <p>",
"    Ospemifene is&nbsp;the first&nbsp;selective estrogen receptor modulator that is effective in treating dyspareunia resulting from menopausal vulvovaginal atrophy. It&nbsp;is an&nbsp;oral medication and&nbsp;may be helpful for women with symptomatic atrophy that is not relieved with vaginal moisturizers or lubricants and who cannot (severe arthritis, obesity, vulvodynia) or prefer not to use a vaginal product. In a&nbsp;randomized trial,&nbsp;12 weeks of ospemifene was significantly more effective than placebo in improving dyspareunia, although the benefit beyond that of placebo was modest [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12180/abstract/11\">",
"     11",
"    </a>",
"    ]. Ospemifene&nbsp;has been approved by the US Food and Drug Administration, but further study is needed to compare it to vaginal estrogen therapy and to&nbsp;evaluate the risk of long-term adverse effects. It is anticipated to be available for clinical use in June 2013. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=see_link&amp;anchor=H2475847#H2475847\">",
"     \"Treatment of vaginal atrophy\", section on 'Selective estrogen receptor modulators'",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4629?source=see_link\">",
"     \"Ospemifene: Drug information\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/1\">",
"      Nelson HD, Walker M, Zakher B, Mitchell J. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations. Ann Intern Med 2012; 157:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/2\">",
"      Moyer VA, U.S. Preventive Services Task Force. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013; 158:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/3\">",
"      Rossouw JE, Manson JE, Kaunitz AM, Anderson GL. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. Obstet Gynecol 2013; 121:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/4\">",
"      Devanand DP, Mintzer J, Schultz SK, et al. Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2012; 367:1497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/5\">",
"      Shorr RI, Chandler AM, Mion LC, et al. Effects of an intervention to increase bed alarm use to prevent falls in hospitalized patients: a cluster randomized trial. Ann Intern Med 2012; 157:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/6\">",
"      Moyer VA, U.S. Preventive Services Task Force. Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/7\">",
"      Coumbe AG, Naksuk N, Newell MC, et al. Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block. Heart 2013; 99:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/8\">",
"      Centers for Disease Control and Prevention (CDC). Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013. MMWR Morb Mortal Wkly Rep 2013; 62:119.",
"     </a>",
"    </li>",
"    <li>",
"     FDA news release. FDA approves first seasonal influenza vaccine manufactured using cell culture technology. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm328982.htm (Accessed on November 26, 2012).",
"    </li>",
"    <li>",
"     Flucelvax prescribing information. file://www.novartisvaccinesdirect.com/pdf/Flucelvax_PI.pdf (Accessed on November 28, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12180/abstract/11\">",
"      Portman DJ, Bachmann GA, Simon JA, and the Ospemifene Study Group. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause 2013.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16437 Version 2390.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-8C00B56BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12180=[""].join("\n");
var outline_f11_57_12180=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      GENERAL GERIATRICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Long-term use of postmenopausal hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Discontinuing antipsychotic agents in patients with dementia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bed alarms for fall prevention in the hospital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      US guidelines for the prevention of falls",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      GERIATRIC CARDIOVASCULAR MEDICINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pacemaker insertion for asymptomatic Mobitz type I second degree AV block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GERIATRIC INFECTIOUS DISEASES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      2012-2013 seasonal influenza vaccine effectiveness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Egg-free influenza vaccine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      GERIATRIC UROLOGY AND UROGYNECOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Ospemifene for treatment of vulvovaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GER/16437\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GER/16437|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/31/42494\" title=\"table 1\">",
"      Influenza vaccines summary",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/4/22602?source=related_link\">",
"      Falls in older persons: Risk factors and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20967?source=related_link\">",
"      Influenza vaccination in individuals with egg allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/33/4629?source=related_link\">",
"      Ospemifene: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=related_link\">",
"      Prevention of falls and complications of falls in community-dwelling older persons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31673?source=related_link\">",
"      Prevention of falls in nursing care facilities and the hospital setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18087?source=related_link\">",
"      Second degree atrioventricular block: Mobitz type I (Wenckebach block)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=related_link\">",
"      Treatment of behavioral symptoms related to dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22250?source=related_link\">",
"      Treatment of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=related_link\">",
"      Treatment of vaginal atrophy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_57_12181="CXR pulmonary artery HT PA";
var content_f11_57_12181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary hypertension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 303px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This plain frontal chest radiograph from a 50-year-old male demonstrates prominence of the interstitial pulmonary markings with enlargement of the right and left ventricle and the right atrium (black arrow). Additionally, large central, but attenuated peripheral pulmonary arteries are noted (white arrow), all features characteristic of pulmonary hypertension.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12181=[""].join("\n");
var outline_f11_57_12181=null;
var title_f11_57_12182="Diphenhydramine (systemic): Patient drug information";
var content_f11_57_12182=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Diphenhydramine (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/33/7705?source=see_link\">",
"     see \"Diphenhydramine (systemic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/48/19207?source=see_link\">",
"     see \"Diphenhydramine (systemic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8082074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aler-Cap [OTC];",
"     </li>",
"     <li>",
"      Aler-Dryl [OTC];",
"     </li>",
"     <li>",
"      Aler-Tab [OTC];",
"     </li>",
"     <li>",
"      AllerMax&reg; [OTC];",
"     </li>",
"     <li>",
"      Altaryl [OTC];",
"     </li>",
"     <li>",
"      Anti-Hist [OTC];",
"     </li>",
"     <li>",
"      Banophen&trade; [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Allergy Quick Dissolve [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Allergy [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Children's Allergy FastMelt&reg; [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Children's Allergy Perfect Measure&trade; [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Children's Allergy [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Children's Dye Free Allergy [OTC];",
"     </li>",
"     <li>",
"      Benadryl&reg; Dye-Free Allergy [OTC];",
"     </li>",
"     <li>",
"      Compoz&reg; [OTC];",
"     </li>",
"     <li>",
"      Diphen [OTC];",
"     </li>",
"     <li>",
"      Diphenhist&reg; [OTC];",
"     </li>",
"     <li>",
"      Geri-Dryl;",
"     </li>",
"     <li>",
"      Histaprin [OTC];",
"     </li>",
"     <li>",
"      Nytol&reg; Quick Caps [OTC];",
"     </li>",
"     <li>",
"      Nytol&reg; Quick Gels [OTC];",
"     </li>",
"     <li>",
"      PediaCare&reg; Children's Allergy [OTC];",
"     </li>",
"     <li>",
"      PediaCare&reg; Children's NightTime Cough [OTC];",
"     </li>",
"     <li>",
"      Q-dryl [OTC];",
"     </li>",
"     <li>",
"      Quenalin [OTC];",
"     </li>",
"     <li>",
"      Siladryl Allergy [OTC];",
"     </li>",
"     <li>",
"      Silphen [OTC];",
"     </li>",
"     <li>",
"      Simply Sleep&reg; [OTC];",
"     </li>",
"     <li>",
"      Sleep-ettes D [OTC];",
"     </li>",
"     <li>",
"      Sleep-Tabs [OTC];",
"     </li>",
"     <li>",
"      Sleepinal&reg; [OTC];",
"     </li>",
"     <li>",
"      Sominex&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Sominex&reg; [OTC];",
"     </li>",
"     <li>",
"      Theraflu&reg; Thin Strips&reg; Multi Symptom [OTC];",
"     </li>",
"     <li>",
"      Twilite&reg; [OTC];",
"     </li>",
"     <li>",
"      Unisom&reg; SleepGels&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Unisom&reg; SleepMelts&trade; [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; ZzzQuil&trade; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8082075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Allerdryl&reg;;",
"     </li>",
"     <li>",
"      Allernix;",
"     </li>",
"     <li>",
"      Benadryl&reg;;",
"     </li>",
"     <li>",
"      Nytol&reg;;",
"     </li>",
"     <li>",
"      Nytol&reg; Extra Strength;",
"     </li>",
"     <li>",
"      PMS-Diphenhydramine;",
"     </li>",
"     <li>",
"      Simply Sleep&reg;;",
"     </li>",
"     <li>",
"      Sominex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10031021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before giving this drug to a child. Check all of your child's drugs, including OTC, with doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691646",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop coughing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691595",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help motion sickness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hives.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692011",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Parkinson's disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling of the face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692082",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat sleep problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700930",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give Benadryl&reg; Children's Allergy Fastmelt&reg; if your child is allergic to peanuts or soybeans.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701959",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to diphenhydramine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703713",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bowel block, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an enlarged prostate, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have PKU, talk with your doctor. Some products have phenylalanine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697831",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use with other products that have diphenhydramine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug for an allergy, it is most useful if started before contact with the allergen. Take at least 1 to 3 hours before.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695176",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug for motion sickness, take 30 minutes before travel.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695172",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug for a sleep problems, take it 1 hour before going to bed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694269",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (elixir, syrup) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral-disintegrating tablet:",
"        </span>",
"       </b>",
"       Place on your tongue and let it melt. Water is not needed. Do not swallow it whole. Do not chew, break, or crush it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694604",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chewable tablet: Chew or crush well. Mix crushed tablet with food. Do not swallow it whole.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11659 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-118.195.65.248-57510F31CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12182=[""].join("\n");
var outline_f11_57_12182=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8082074\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8082075\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031021\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031023\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031022\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031027\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031028\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031030\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031025\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031026\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031031\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031032\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/33/7705?source=related_link\">",
"      Diphenhydramine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/48/19207?source=related_link\">",
"      Diphenhydramine (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?1/15/1269?source=related_link\">",
"      Diphenhydramine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?4/10/4260?source=related_link\">",
"      Diphenhydramine (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?12/51/13108?source=related_link\">",
"      Diphenhydramine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_57_12183="Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults";
var content_f11_57_12183=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12183/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12183/contributors\">",
"     Thomas M File, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12183/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12183/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12183/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12183/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/57/12183/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hospital-acquired (or nosocomial) pneumonia (HAP), ventilator-associated pneumonia (VAP), and healthcare-associated pneumonia (HCAP) are important causes of morbidity and mortality despite improved antimicrobial therapy, supportive care, and prevention [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, and microbiology of HAP, VAP, and HCAP will be reviewed here. The diagnosis, risk factors, prevention, and treatment of HAP, VAP, and HCAP are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24040?source=see_link\">",
"     \"Clinical presentation and diagnosis of ventilator-associated pneumonia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=see_link\">",
"     \"Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36858?source=see_link\">",
"     \"Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pneumonia types",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2005 American Thoracic",
"    <span class=\"nowrap\">",
"     Society/Infectious",
"    </span>",
"    Diseases Society of America",
"    <span class=\"nowrap\">",
"     (ATS/IDSA)",
"    </span>",
"    guidelines on the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia used the following definitions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hospital-acquired (or nosocomial) pneumonia (HAP) is pneumonia that occurs 48 hours or more after admission and did not appear to be incubating at the time of admission.",
"     </li>",
"     <li>",
"      Ventilator-associated pneumonia (VAP) is a type of HAP that develops more than 48 to 72 hours after endotracheal intubation.",
"     </li>",
"     <li>",
"      Healthcare-associated pneumonia (HCAP) is defined as pneumonia that occurs in a non-hospitalized patient with extensive healthcare contact, as defined by one or more of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Intravenous therapy, wound care, or intravenous chemotherapy within the prior 30 days",
"     </li>",
"     <li>",
"      Residence in a nursing home or other long-term care facility",
"     </li>",
"     <li>",
"      Hospitalization in an acute care hospital for two or more days within the prior 90 days",
"     </li>",
"     <li>",
"      Attendance at a hospital or hemodialysis clinic within the prior 30 days",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    HCAP was added as a category of pneumonia in the 2005",
"    <span class=\"nowrap\">",
"     ATS/IDSA",
"    </span>",
"    guidelines in order to identify patients at increased risk for multidrug-resistant (MDR) pathogens coming from community settings; such individuals would previously have been classified as having community-acquired pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. However, the definition of HCAP is being reevaluated since some authorities have argued that it is an overgeneralization to consider all HCAP patients at increased risk for MDR pathogens. The challenge for clinicians is to correctly identify the HCAP patient who is most likely to benefit from empiric treatment with broad-spectrum antibiotics with activity against MDR pathogens. The clinical issues surrounding HCAP are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36858?source=see_link&amp;anchor=H249925653#H249925653\">",
"     \"Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\", section on 'Approach to therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The guidelines can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements/\">",
"     file://www.thoracic.org/statements/",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Multidrug resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definition of multidrug resistance in gram-negative bacilli, which are an important cause of HAP, VAP, and HCAP, is variably defined as resistance to at least two, three, four, or eight of the antibiotics typically used to treat infections with these organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Panresistance refers to those gram-negative organisms with diminished susceptibility to all of the antibiotics recommended for the empiric treatment of VAP, including,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/33/16919?source=see_link\">",
"     cefepime",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    , imipenem,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/38/32359?source=see_link\">",
"     meropenem",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36858?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\", section on 'Empiric treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;HAP is the leading cause of death among hospital-acquired infections, with estimates of HAP-associated mortality ranging from 20 to 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/1,2,5,6\">",
"     1,2,5,6",
"    </a>",
"    ]. In contrast, data on HAP-attributable mortality conflict. While some studies indicate an attributable mortality of 33 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/7,8\">",
"     7,8",
"    </a>",
"    ], another suggests that pneumonia is not a significant risk factor for death after adjusting for other predictors of mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most cases of HAP occur outside of intensive care units. However, the highest risk for HAP is in patients on mechanical ventilation (ie, VAP), in whom the entity has been best studied. Estimates of incidence range from four to seven episodes per 1000 hospitalizations, accounting for 13 to 18 percent of all nosocomial infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of HAP, VAP, and HCAP is related to the number and virulence of microorganisms entering the lower respiratory tract and the response of the host (eg, mechanical, humoral, and cellular host defenses). The primary route of infection of the lungs is through microaspiration of organisms that have colonized the oropharyngeal tract (or, to lesser extent, the gastrointestinal tract). Approximately 45 percent of healthy subjects aspirate during sleep, and an even higher proportion of severely ill patients aspirate routinely [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/6\">",
"     6",
"    </a>",
"    ]. Although frequently regarded as partially protective, the presence of an endotracheal tube permits the aspiration of oropharyngeal material or bacteria of gastrointestinal origin. Depending upon the number and virulence of the organisms reaching the lung, pneumonia may ensue.",
"   </p>",
"   <p>",
"    Hospitalized patients often become colonized with microorganisms acquired from the hospital environment, and as many as 75 percent of severely ill patients will be colonized within 48 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/6,10,11\">",
"     6,10,11",
"    </a>",
"    ]. The most common mechanism of infection in mechanically ventilated patients is direct contact with environmental reservoirs, including respiratory devices and contaminated water reservoirs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Such contamination frequently occurs despite rigorous cleaning of ventilator equipment because disposable tubing used in respiratory circuits or tracheostomy or endotracheal tubes may become contaminated in the process of routine nursing care or via the (contaminated) hands of hospital personnel.",
"   </p>",
"   <p>",
"    In addition, the near sterility of the stomach and upper gastrointestinal tract may be disrupted by alterations in gastric pH due to illness, medications, or enteric feedings. For this reason, much attention has been paid to the possible adverse effect of ulcer prophylaxis regimens that raise the gastric pH. Less frequently, pneumonia results from inhalation of infectious aerosols or from bacteremia originating in a distant focus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=see_link&amp;anchor=H6#H6\">",
"     \"Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\", section on 'Role of gastric pH'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;HAP, VAP, and HCAP may be caused by a wide variety of pathogens and can be polymicrobial. Common pathogens include aerobic gram-negative bacilli (eg, Escherichia coli, Klebsiella pneumoniae, Enterobacter spp, Pseudomonas aeruginosa, Acinetobacter spp) and gram-positive cocci (eg, Staphylococcus aureus, including methicillin-resistant S. aureus [MRSA], Streptococcus spp) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/14\">",
"     14",
"    </a>",
"    ]. Nosocomial pneumonia due to viruses or fungi is significantly less common, except in the immunocompromised patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ventilator-associated and hospital-acquired pneumonia (VAP and HAP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of data regarding whether the pathogens that cause VAP differ from those that cause HAP in patients who are not mechanically ventilated. One prospective observational study evaluated 158,519 patients admitted to a single center over a four year period [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/15\">",
"     15",
"    </a>",
"    ]. A total of 327 episodes of VAP and 261 episodes of HAP in non-ventilated patients were identified:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The infecting flora in patients with VAP included MSSA (nine percent), MRSA (18 percent), P. aeruginosa (18 percent), Stenotrophomonas maltophilia (7 percent), Acinetobacter spp (8 percent), and other spp (9 percent).",
"     </li>",
"     <li>",
"      The infecting flora in non-ventilated patients with HAP was similar, except non-Enterobacteriaciae gram-negative bacilli (P. aeruginosa, Acinetobacter, and S. maltophilia) were less likely. Specifically, it included MSSA (13 percent), MRSA (20 percent), P. aeruginosa (9 percent), S. maltophilia (1 percent), Acinetobacter spp (3 percent), and other spp (18 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings are supported by a prospective, multicenter, observational study of 398 ICU patients with suspected VAP [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/16\">",
"     16",
"    </a>",
"    ]. In this study, there was a similar distribution of pathogens &mdash; MRSA (14.8 percent), P. aeruginosa (14.3 percent), and other Staphylococcus species (8.8 percent).",
"   </p>",
"   <p>",
"    A frequent criticism of such studies is that they may underestimate the prevalence of certain pathogens (eg, anaerobes) because special culturing techniques are required to identify them. However, a study performed anaerobic cultures using protective brush specimens and bronchoalveolar lavage fluid from 185 patients with possible VAP identified only one anaerobic organism, nonpathogenic Veillonella spp [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/17\">",
"     17",
"    </a>",
"    ]. This suggests that the practice of including anaerobic coverage in the treatment of VAP is unnecessary.",
"   </p>",
"   <p>",
"    Differences in host factors and in the hospital flora of an institution also influence the patterns of pathogens seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Healthcare-associated pneumonia (HCAP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical and microbiologic features of HCAP are more similar to HAP and VAP than to CAP but the incidence of specific pathogens varies with the population studied [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/3,18-20\">",
"     3,18-20",
"    </a>",
"    ]. Most patients included in these studies were recently hospitalized or had been transferred from nursing homes. Principles from these studies are illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective cohort study of 4543 patients with pneumonia occurring within the first five days of admission to United States hospitals between January 2002 and December 2003 examined the distribution of pathogens responsible for HCAP compared to HAP or CAP [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/3\">",
"       3",
"      </a>",
"      ]. The incidence of S. aureus in the HCAP and HAP groups were comparable (47 percent) and significantly higher than in the CAP group (26 percent). The rate of MRSA infection was also higher in HCAP and HAP patients compared to CAP (27 and 23 versus 9 percent for CAP). Besides S. aureus, P. aeruginosa was the only other pathogen with a significant occurrence (25 percent) in HCAP patients.",
"     </li>",
"     <li>",
"      A prospective observational analysis of 727 cases of pneumonia from Spain compared the etiology of 126 cases of HCAP and 601 cases of CAP [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/19\">",
"       19",
"      </a>",
"      ]. The most common organism in both groups was S. pneumoniae; however, drug-resistant strains were more common in patients with HCAP. Legionella was more common in CAP, but aspiration, H. influenzae, and gram-negative bacilli were more common in HCAP. S. aureus was also more common in patients with HCAP, but the incidence was substantially lower than in the previous study (2.4 percent for HCAP versus 0 percent for CAP).",
"     </li>",
"     <li>",
"      In a multicenter, prospective observational study from 55 hospitals in Italy, 362 patients were hospitalized during two one-week periods [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/20\">",
"       20",
"      </a>",
"      ]. Among these, 62 percent of patients had CAP, 25 percent had HCAP, and 14 percent had HAP. Patients with HCAP had higher mortality (18 versus 7 percent) and longer length of hospitalization (19 versus 15) compared with CAP patients. However, the great majority of patients classified as having HCAP were those who had been hospitalized within 180 days (a longer period than the 90 days included in the definition of HCAP in the",
"      <span class=\"nowrap\">",
"       ATS/IDSA",
"      </span>",
"      Guidelines) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     MDR risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of HAP, VAP, and HCAP depends upon whether the patient has risk factors for multidrug-resistant (MDR) pathogens [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/2\">",
"     2",
"    </a>",
"    ]. The frequency of specific MDR pathogens varies among hospitals, specific hospital units, and patient populations including those with recent exposure to antibiotics. An awareness of the susceptibility patterns of the nosocomial pathogens within a given healthcare setting is important for appropriate empiric antimicrobial therapy. The frequency of MDR bacteria as etiologic agents of HAP is increasing, especially among patients in ICUs.",
"   </p>",
"   <p>",
"    Host risk factors for infection with MDR pathogens include [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Receipt of antibiotics within the preceding 90 days",
"     </li>",
"     <li>",
"      Current hospitalization of &ge;5 days",
"     </li>",
"     <li>",
"      High frequency of antibiotic resistance in the community or in the specific hospital unit",
"     </li>",
"     <li>",
"      Immunosuppressive disease",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      therapy",
"     </li>",
"     <li>",
"      Patients with HCAP are at variable risk for infection due to MDR pathogens. In a recent review of studies of HCAP published since the development of the",
"      <span class=\"nowrap\">",
"       ATS/IDSA",
"      </span>",
"      guidelines, specific risk factors for MDR pathogens associated with HCAP included hospitalization for &ge;2 days during the preceding 90 days, severe illness, antibiotic therapy in the past 6 months, poor functional status as defined by activities of daily living score, and immune suppression [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/21\">",
"       21",
"      </a>",
"      ]. The risk factor of long-term care facility (LTCF) residence applies specifically to those who have more severe illness, prior antibiotic therapy in the preceding six months, or poor functional status as defined by activities of daily living score [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/18,22\">",
"       18,22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical diagnosis of HAP, VAP, and HCAP is difficult in part because the clinical findings are nonspecific. The 2005",
"    <span class=\"nowrap\">",
"     ATS/IDSA",
"    </span>",
"    guidelines on the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia did not provide specific criteria for the diagnosis of these disorders. The guidelines concluded that HAP, VAP, or HCAP should be suspected in patients with a new or progressive infiltrate on lung imaging as well as clinical characteristics such as [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fever",
"     </li>",
"     <li>",
"      Purulent sputum",
"     </li>",
"     <li>",
"      Leukocytosis",
"     </li>",
"     <li>",
"      Decline in oxygenation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of a new or progressive radiographic infiltrate plus at least two of the three clinical features (fever &gt;38&ordm;C, leukocytosis or leukopenia, and purulent secretions) represents a clinically relevant combination of criteria for starting empiric antimicrobial therapy. When findings at autopsy are used as a standard of reference, this combination of findings resulted in 69 percent sensitivity and 75 percent specificity for pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12183/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnostic approach to VAP is similar, and is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24040?source=see_link\">",
"     \"Clinical presentation and diagnosis of ventilator-associated pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of sputum cultures is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17591?source=see_link\">",
"     \"Sputum cultures for the evaluation of bacterial pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/1/19474?source=see_link\">",
"       \"Patient information: Hospital-acquired pneumonia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The following types of nosocomial pneumonia have been defined:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hospital-acquired pneumonia (HAP) is pneumonia that occurs 48 hours or more after admission, and did not appear to be incubating at the time of admission.",
"     </li>",
"     <li>",
"      Ventilator-associated pneumonia (VAP) is a type of HAP that develops more than 48 to 72 hours after endotracheal intubation.",
"     </li>",
"     <li>",
"      Healthcare-associated pneumonia (HCAP) includes pneumonia in any patient who was either hospitalized in an acute care hospital for two or more days within 90 days of the infection; or resided in a long term care facility; or received intravenous antimicrobial therapy, chemotherapy, or wound care within the 30 days prior to the current infection; or attends a hospital or hemodialysis clinic. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multidrug resistance (MDR) in gram-negative bacilli, which are an important cause of HAP, VAP, and HCAP is variably defined as resistance to at least two, three, four, or eight of the antibiotics typically used to treat infections with these organisms. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HAP is the leading cause of death among hospital-acquired infections. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of HAP, VAP, and HCAP is related to the numbers and virulence of microorganisms entering the lower respiratory tract and the response of the host. The primary route of infection of the lungs is through microaspiration of organisms, which have colonized the oropharyngeal tract (or to lesser extent the gastrointestinal tract). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HAP, VAP, and HCAP may be caused by a wide variety of pathogens, can be polymicrobial, and may be due to MDR pathogens. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The frequency of MDR bacteria as etiologic agents of HAP, VAP, and HCAP is increasing, especially among patients in intensive care units",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      patients with certain risk factors. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'MDR risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of HAP, VAP, and HCAP should be suspected in patients with a new or progressive infiltrate on lung imaging as well as clinical characteristics such as fever, purulent sputum, leukocytosis,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      decline in oxygenation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/1\">",
"      Guideline for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. Respir Care 1994; 39:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/2\">",
"      American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/3\">",
"      Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/4\">",
"      Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 Suppl 2:S43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/5\">",
"      Craven DE, Palladino R, McQuillen DP. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect Dis Clin North Am 2004; 18:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/6\">",
"      Scheld WM. Developments in the pathogenesis, diagnosis and treatment of nosocomial pneumonia. Surg Gynecol Obstet 1991; 172 Suppl:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/7\">",
"      Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/8\">",
"      Pingleton SK, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest 1992; 102:553S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/9\">",
"      Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/10\">",
"      Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005; 50:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/11\">",
"      Garrouste-Orgeas M, Chevret S, Arlet G, et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997; 156:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/12\">",
"      Nseir S, Di Pompeo C, Pronnier P, et al. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 2002; 20:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/13\">",
"      Rello J, Quintana E, Ausina V, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991; 100:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/14\">",
"      Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010; 51 Suppl 1:S81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/15\">",
"      Weber DJ, Rutala WA, Sickbert-Bennett EE, et al. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol 2007; 28:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/16\">",
"      Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/17\">",
"      Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest 1999; 115:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/18\">",
"      Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. Clin Infect Dis 2008; 46 Suppl 4:S296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/19\">",
"      Carratal&agrave; J, Mykietiuk A, Fern&aacute;ndez-Sab&eacute; N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/20\">",
"      Venditti M, Falcone M, Corrao S, et al. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/21\">",
"      Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 2009; 22:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/22\">",
"      El Solh AA, Pietrantoni C, Bhat A, et al. Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin Infect Dis 2004; 39:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12183/abstract/23\">",
"      F&agrave;bregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54:867.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7020 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-0D0D3C1A28-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12183=[""].join("\n");
var outline_f11_57_12183=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pneumonia types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Multidrug resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ventilator-associated and hospital-acquired pneumonia (VAP and HAP)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Healthcare-associated pneumonia (HCAP)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MDR risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24040?source=related_link\">",
"      Clinical presentation and diagnosis of ventilator-associated pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/1/19474?source=related_link\">",
"      Patient information: Hospital-acquired pneumonia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=related_link\">",
"      Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/11/17591?source=related_link\">",
"      Sputum cultures for the evaluation of bacterial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36858?source=related_link\">",
"      Treatment of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_57_12184="Prevention and control of Clostridium difficile in hospital and institutional settings";
var content_f11_57_12184=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention and control of Clostridium difficile in hospital and institutional settings",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12184/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12184/contributors\">",
"     Jay R McDonald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12184/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12184/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12184/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12184/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/57/12184/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clostridium difficile is the most frequent cause of nosocomial diarrhea, and a significant cause of morbidity and mortality among hospitalized patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/1\">",
"     1",
"    </a>",
"    ]. Studies have suggested that both the incidence and severity of C. difficile infection (CDI) are increasing and that inpatient health care facilities are the primary site of C. difficile transmission. In addition, there are substantial short- and long-term attributable costs associated with C. difficile infection [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=see_link&amp;anchor=H3#H3\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\", section on 'Nosocomial infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    C. difficile colonizes the colon of about 2 percent of healthy adults [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/3\">",
"     3",
"    </a>",
"    ]. It is shed into the environment by people who are colonized or infected. New colonization occurs predominantly by the fecal-oral route. Patients who become colonized are subsequently at risk for developing CDI, primarily after treatment with antibiotics. Thus, efforts to prevent and control C. difficile can focus on two goals:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prevention of new colonization with the organism",
"     </li>",
"     <li>",
"      Prevention of CDI among patients already colonized by the organism",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prevention and control of C. difficile requires a variety of interventions. This was illustrated in a report of a C. difficile hypervirulent strain outbreak in an 834 bed hospital; the outbreak was successfully controlled with introduction of successive, tiered interventions with the guidance of ongoing surveillance [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/4\">",
"     4",
"    </a>",
"    ]. The components of this approach will be reviewed here [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/5\">",
"     5",
"    </a>",
"    ]. The pathophysiology, epidemiology, clinical manifestations, and treatment of CDI are discussed separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INFECTION CONTROL",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healthcare facilities should track rates of CDI using standard surveillance definitions [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/6\">",
"     6",
"    </a>",
"    ]. CDI should be grouped into three categories: (1) health-care facility (HCF)-onset, HCF-associated; (2) community-onset, HCF-associated; and (3) community-associated CDI [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/7\">",
"     7",
"    </a>",
"    ]. These surveillance data can be used to compare rates with other facilities as well as against historical rates within the same facility. Rising CDI rates or CDI rates above published benchmarks should prompt further investigation and intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Contact precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with suspected or proven C. difficile infection should be placed on contact precautions, including gloves and gowns. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link&amp;anchor=H10#H10\">",
"     \"General principles of infection control\", section on 'Isolation precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Precautions should be continued for the duration of diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/6\">",
"     6",
"    </a>",
"    ]. Some data suggest that skin contamination with C. difficile may persist after resolution of diarrhea, and it may be reasonable to continue contact precautions until discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/8\">",
"     8",
"    </a>",
"    ]; further study is needed to clarify the infection control risk associated with C. difficile spores that persist after resolution of diarrhea.",
"   </p>",
"   <p>",
"    Symptomatic patients may also play a role in airborne dispersal of C. difficile. In a study including 50 patients with confirmed C. difficile infection, air sampling for one hour yielded C. difficile in 12 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hand hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcohol-based hand rub (ABHR) is recommended over soap and water in the control of most organisms of epidemiologic importance [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link&amp;anchor=H3#H3\">",
"     \"General principles of infection control\", section on 'Hand hygiene'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, ABHR does NOT eradicate C. difficile spores from the hands of healthcare workers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. Because proper handwashing with soap and water involves vigorous mechanical scrubbing and rinsing, it may be more effective than other hand hygiene products in physically removing bacterial spores from the hands. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link\">",
"     \"General principles of infection control\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There has been concern that widespread use of ABHR has played a role in recent C. difficile outbreaks. Furthermore, because soap and water hand hygiene requires more time than ABHR, there is concern that avoidance may decrease overall hand hygiene compliance. These concerns remain unproven; overall CDI rates have tended to decrease or remain the same after introduction and increased use of alcohol-based sanitizers as the primary mode of hand hygiene [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nonetheless, the Centers for Disease Control and Prevention recommends soap and water hand hygiene when caring for patients with CDI [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/10\">",
"     10",
"    </a>",
"    ]. If a facility is experiencing a C. difficile outbreak, it is prudent to emphasize that health care workers should wash their hands with soap and water in addition to an ABHR [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/6,17,18\">",
"     6,17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5992138\">",
"    <span class=\"h2\">",
"     Stethoscope disinfection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stethoscopes can be contaminated with C. difficile spores by exposure to contaminated surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/19\">",
"     19",
"    </a>",
"    ]. Following examination of patients healthcare workers should disinfect stethoscopes with alcohol wipes or gauze moistened with sterile water or alcohol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cohorting",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. difficile causes heavy contamination of the patient environment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/20\">",
"     20",
"    </a>",
"    ]. Horizontal transmission of C. difficile is facilitated by sharing a room with a patient with CDI [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/21\">",
"     21",
"    </a>",
"    ]. Whenever possible, patients with CDI should be assigned a single room with a private bathroom. When cohorting is necessary, each patient in a shared room should have a dedicated commode [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26772977\">",
"    <span class=\"h2\">",
"     Chlorhexidine bathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/36/12870?source=see_link\">",
"     Chlorhexidine",
"    </a>",
"    (CHG) bathing may reduce hospital-acquired C. difficile infections. This was illustrated in a study including administration of more than 68,000 CHG baths over an 18-month period, during which the incidence of C. difficile infection decreased with bathing daily (relative risk [RR] 0.41, 95% CI 0.29-0.59) or three times weekly (RR 0.71, 95% CI 0.57-0.89) compared with a one-year baseline observation period [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     HOSPITAL ENVIRONMENTAL CLEANING",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. difficile spores can survive on dry surfaces for up to several months. Therefore, environmental cleaning in the setting of patient care for CDI requires special attention [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/21,23-27\">",
"     21,23-27",
"    </a>",
"    ]. Few studies have examined the use of cleaning agents for the inactivation of C. difficile spores [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/28-30\">",
"     28-30",
"    </a>",
"    ], and few studies have been conducted to determine efficacy of surface disinfection and its impact on health-care&ndash;associated diarrhea.",
"   </p>",
"   <p>",
"    Hypochlorite-based solutions are more effective than some other solutions for eradicating C. difficile from the environment. This was illustrated in a study of environmental cleaning solutions in which a 1:10 hypochlorite solution was substituted for quaternary ammonium in three hospital units [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/29\">",
"     29",
"    </a>",
"    ]. The rate of CDI decreased significantly on the bone marrow transplant unit, from 8.6 to 3.3 cases per 1000 patient-days. After reverting back to quaternary ammonium, the rate returned to 8.1 per 1000 patient-days. In comparison, no significant change was observed in two other units with lower baseline rates of 1.3 to 3.0 cases per 1000 patient-days.",
"   </p>",
"   <p>",
"    Products that appear to reliably kill C. difficile spores contain at least 5000 parts per million of sodium hypochlorite and can cause caustic damage to the surfaces of hospital equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Nonetheless, use of such a solution should be considered for environmental cleaning of rooms and bathrooms used by patients with CDI, particularly in the setting of an outbreak [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/28,31-33\">",
"     28,31-33",
"    </a>",
"    ]. Based upon the available evidence, the CDC recommends use of a hypochlorite-based solution in the setting of CDI [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multiuse medical equipment such as blood pressure cuffs and thermometers has been implicated in horizontal transmission of C. difficile [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Cleaning of multi-use medical equipment should be performed using a sporicidal agent. Whenever possible, single-use alternatives should be used [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ANTIBIOTIC RESTRICTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of antibiotics has been definitively linked to both colonization and disease caused by C. difficile. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=see_link&amp;anchor=H5#H5\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\", section on 'Antibiotics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Targeted restriction of a particular antimicrobial agent or class of agents has led to control of individual hospital outbreaks and to reduced community CDI rates [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. Implementation of an antimicrobial stewardship program during the Quebec outbreak in the early 2000s led to a decrease in incidence of nosocomial CDI by 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/36\">",
"     36",
"    </a>",
"    ]. Although no formal restrictions were applied, targeted antibiotics included cephalosporins,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , and macrolides. Where possible, recommendations included avoidance of clindamycin and use of aminoglycosides or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    rather than fluoroquinolones. Duration of antibiotics was limited as appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Clindamycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;In several C. difficile outbreaks in the 1990s,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    restrictions were followed by rapid reductions in CDI cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. This was also evident in the control of outbreaks caused by the highly clindamycin-resistant J strain [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/39\">",
"     39",
"    </a>",
"    ]. In one study, for example, a policy requiring infectious disease physician approval for clindamycin use led to a significant and sustained reduction in CDI from 11.5 to 3.3 cases per month [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=see_link\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Fluoroquinolones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoroquinolone use appears to be a class effect in outbreaks caused by the hypervirulent",
"    <span class=\"nowrap\">",
"     NAP1/BI/027",
"    </span>",
"    strain, since the rates in two studies were similar with different fluoroquinolones [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. Thus, restriction or reduced use of all fluoroquinolones may be required for effective control [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=see_link&amp;anchor=H11#H11\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\", section on 'Hypervirulent strain: NAP1/BI/027'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cephalosporins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Restriction of third generation cephalosporins has been successful in reducing CDI rates in some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/37,38,45-47\">",
"     37,38,45-47",
"    </a>",
"    ]. In one study, for example, the risk of CDI was significantly lower after empiric treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    rather than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/45\">",
"     45",
"    </a>",
"    ]. In other reports, formulary restrictions reduced CDI rates by minimizing inappropriate cephalosporin use [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/37\">",
"     37",
"    </a>",
"    ] and by limiting antibiotics to penicillin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , and aminoglycosides in the setting of an outbreak [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     HOME HYGIENE",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. difficile can be spread to household contacts, although it is rare for otherwise healthy individuals to become ill with symptomatic C. difficile disease in the absence of antibiotics. To prevent spread to household contacts, patients with C. difficile should wash hands frequently with soap and water, especially after using the bathroom and before food preparation. Patients with diarrhea should avoid using the same toilet as other family members. In addition, bathroom and kitchen areas (including toilet seats, toilet bowl, flush handle, sink faucet handles and countertops) may be cleaned with a mixture of bleach and water (1 part bleach to every 10 parts water) to help prevent the spread of C. difficile.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     AREAS OF INVESTIGATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Use of probiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to probiotics are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21015?source=see_link\">",
"     \"Clostridium difficile and probiotics\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have shown that the humoral immune response of the host to C. difficile toxins A and B influences the clinical course of CDI as well as the risk of relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. Thus, vaccination with a partially purified preparation of inactivated toxins A and B may be a viable strategy for active immunization [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A vaccine containing toxoids A and B has been shown to induce adequate antibody responses in healthy volunteers [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/52\">",
"     52",
"    </a>",
"    ]. The efficacy of this vaccine was subsequently evaluated in an open-label study in three patients with recurrent C. difficile colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/53\">",
"     53",
"    </a>",
"    ]. Following four intramuscular inoculations over an eight week period, all three patients discontinued antibiotic treatment without further recurrence during a six-month follow-up.",
"   </p>",
"   <p>",
"    These results support the feasibility of active vaccination but efficacy must be validated in larger, randomized, controlled trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Treatment of asymptomatic carriers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymptomatically colonized patients can act as a reservoir for transmission of CDI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=see_link\">",
"     \"Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data are limited regarding whether treatment of asymptomatic carriers might lead to a decrease in nosocomial transmission of C. difficile. In a small trial, 30 asymptomatic C. difficile carriers were randomly assigned to one of three treatment groups: oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    125 mg four times daily;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    500 mg orally twice daily; or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12184/abstract/54\">",
"     54",
"    </a>",
"    ]. Nine of ten patients receiving vancomycin became culture-negative during and immediately after treatment, compared to three of ten receiving metronidazole and two of ten receiving placebo. However, decolonization was transient, as most patients became recolonized within weeks.",
"   </p>",
"   <p>",
"    Thus,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    does not appear to be effective for treatment of asymptomatic carriers.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     Vancomycin",
"    </a>",
"    may be useful for transient elimination of the carrier state, although routine treatment is not recommended. In the setting of a hospital outbreak in which temporary elimination of the organism is felt necessary to reduce horizontal transmission, vancomycin may be a useful tool, although further study is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/47/28402?source=see_link\">",
"       \"Patient information: Antibiotic-associated diarrhea (C. difficile infection) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/52/19267?source=see_link\">",
"       \"Patient information: Antibiotic-associated diarrhea caused by Clostridium difficile (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prevention and control of Clostridium difficile infection (CDI) in healthcare settings requires careful attention to hand hygiene, contact precautions, and environmental cleaning. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Infection control'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Hospital environmental cleaning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibiotic restriction can reduce C. difficile rates; strategies for antibiotic use should be tailored to health care delivery in particular institutions. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Antibiotic restriction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is insufficient data for routine treatment of asymptomatic carriers or vaccination. Issues related to probiotics are discussed separately. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment of asymptomatic carriers'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Vaccination'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21015?source=see_link\">",
"       \"Clostridium difficile and probiotics\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/1\">",
"      Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/2\">",
"      Dubberke ER, Reske KA, Olsen MA, et al. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/3\">",
"      Aronsson B, M&ouml;llby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 1985; 151:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/4\">",
"      Muto CA, Blank MK, Marsh JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive \"bundle\" approach. Clin Infect Dis 2007; 45:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/5\">",
"      Centers for Disease Control and Prevention (CDC). Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012; 61:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/6\">",
"      Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/7\">",
"      McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/8\">",
"      Bobulsky GS, Al-Nassir WN, Riggs MM, et al. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 2008; 46:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/9\">",
"      Best EL, Fawley WN, Parnell P, Wilcox MH. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis 2010; 50:1450.",
"     </a>",
"    </li>",
"    <li>",
"     Siegel JD, Rhinehart E, Jackson M, et al. Healthcare Infection Control Practices Advisory Committee 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, June 2007 (file://www.cdc.gov/ncidod/dhqp/gl_isolation.html) Accessed August 10, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/11\">",
"      Bettin K, Clabots C, Mathie P, et al. Effectiveness of liquid soap vs. chlorhexidine gluconate for the removal of Clostridium difficile from bare hands and gloved hands. Infect Control Hosp Epidemiol 1994; 15:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/12\">",
"      Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/13\">",
"      Jabbar U, Leischner J, Kasper D, et al. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 2010; 31:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/14\">",
"      Oughton MT, Loo VG, Dendukuri N, et al. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 2009; 30:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/15\">",
"      Boyce JM, Ligi C, Kohan C, et al. Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 2006; 27:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/16\">",
"      Gordin FM, Schultz ME, Huber RA, Gill JA. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol 2005; 26:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/17\">",
"      McDonald LC. Clostridium difficile: responding to a new threat from an old enemy. Infect Control Hosp Epidemiol 2005; 26:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/18\">",
"      Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002; 23:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/19\">",
"      Vajravelu RK, Guerrero DM, Jury LA, Donskey CJ. Evaluation of stethoscopes as vectors of Clostridium difficile and methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2012; 33:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/20\">",
"      Dubberke ER, Reske KA, Noble-Wang J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007; 35:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/21\">",
"      McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/22\">",
"      Rupp ME, Cavalieri RJ, Lyden E, et al. Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections. Infect Control Hosp Epidemiol 2012; 33:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/23\">",
"      Samore MH, Venkataraman L, DeGirolami PC, et al. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/24\">",
"      Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/25\">",
"      Savage AM, Alford RH. Nosocomial spread of Clostridium difficile. Infect Control 1983; 4:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/26\">",
"      Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/27\">",
"      Brooks SE, Veal RO, Kramer M, et al. Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992; 13:98.",
"     </a>",
"    </li>",
"    <li>",
"     CDC Guidelines for Environmental Infection Control in Health-Care Facilities, 2003 (file://www.cdc.gov/ncidod/dhqp/id_Cdiff_excerpts.html) Accessed August 15, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/29\">",
"      Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000; 31:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/30\">",
"      Wilcox MH, Fawley WN, Wigglesworth N, et al. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003; 54:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/31\">",
"      Simor AE, Bradley SF, Strausbaugh LJ, et al. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002; 23:696.",
"     </a>",
"    </li>",
"    <li>",
"     Sehulster, LM, Chinn, RY, Arduino, MJ, et al. Guidelines for environmental infection control in health-care facilities. Recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Chicago IL; American Society for Healthcare Engineering/American Hospital Association; 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/33\">",
"      Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/34\">",
"      Manian FA, Meyer L, Jenne J. Clostridium difficile contamination of blood pressure cuffs: a call for a closer look at gloving practices in the era of universal precautions. Infect Control Hosp Epidemiol 1996; 17:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/35\">",
"      Jernigan JA, Siegman-Igra Y, Guerrant RC, Farr BM. A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections. Infect Control Hosp Epidemiol 1998; 19:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/36\">",
"      Valiquette L, Cossette B, Garant MP, et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007; 45 Suppl 2:S112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/37\">",
"      Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/38\">",
"      McNulty C, Logan M, Donald IP, et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother 1997; 40:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/39\">",
"      Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999; 341:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/40\">",
"      Pear SM, Williamson TH, Bettin KM, et al. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994; 120:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/41\">",
"      Climo MW, Israel DS, Wong ES, et al. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998; 128:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/42\">",
"      Biller P, Shank B, Lind L, et al. Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol 2007; 28:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/43\">",
"      McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/44\">",
"      Labb&eacute; AC, Poirier L, Maccannell D, et al. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob Agents Chemother 2008; 52:3180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/45\">",
"      Settle CD, Wilcox MH, Fawley WN, et al. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Aliment Pharmacol Ther 1998; 12:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/46\">",
"      Khan R, Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J Hosp Infect 2003; 54:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/47\">",
"      Nelson DE, Auerbach SB, Baltch AL, et al. Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infect Control Hosp Epidemiol 1994; 15:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/48\">",
"      Aronsson B, Granstr&ouml;m M, M&ouml;llby R, Nord CE. Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection 1985; 13:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/49\">",
"      Leung DY, Kelly CP, Boguniewicz M, et al. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991; 118:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/50\">",
"      Warny M, Vaerman JP, Avesani V, Delm&eacute;e M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994; 62:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/51\">",
"      Aboudola S, Kotloff KL, Kyne L, et al. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun 2003; 71:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/52\">",
"      Kotloff KL, Wasserman SS, Losonsky GA, et al. Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun 2001; 69:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/53\">",
"      Sougioultzis S, Kyne L, Drudy D, et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 2005; 128:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12184/abstract/54\">",
"      Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med 1992; 117:297.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2687 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-704953041C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12184=[""].join("\n");
var outline_f11_57_12184=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INFECTION CONTROL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Surveillance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Contact precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hand hygiene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5992138\">",
"      Stethoscope disinfection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cohorting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26772977\">",
"      Chlorhexidine bathing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      HOSPITAL ENVIRONMENTAL CLEANING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ANTIBIOTIC RESTRICTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Clindamycin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Fluoroquinolones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cephalosporins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      HOME HYGIENE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      AREAS OF INVESTIGATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Use of probiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Treatment of asymptomatic carriers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21015?source=related_link\">",
"      Clostridium difficile and probiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36137?source=related_link\">",
"      Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/47/28402?source=related_link\">",
"      Patient information: Antibiotic-associated diarrhea (C. difficile infection) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/52/19267?source=related_link\">",
"      Patient information: Antibiotic-associated diarrhea caused by Clostridium difficile (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_57_12185="Hemopneumothorax I PA";
var content_f11_57_12185=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58226%7EPULM%2F80846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58226%7EPULM%2F80846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 509px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of hemopneumothorax due to blunt trauma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 489px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: Supine chest radiograph shows hyperexpansion of the left hemithorax with filter effect and veil-like opacification due to dorsal blood and ventral gas. Right panel: After insertion of chest tubes, the dorsal component of blood has been drained, and only the pneumothorax remains. The contused lung is too rigid and noncompliant to completely collapse.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of hemopneumothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hemopneumothorax after gunshot wound to the left hemithorax. Supine chest radiograph shows left pleural effusion, small left inferolateral pneumothorax, left lung contusion, and marked cardiomediastinal shift to the right. A right pneumothorax is also present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12185=[""].join("\n");
var outline_f11_57_12185=null;
var title_f11_57_12186="Severe extremity injury in the adult patient";
var content_f11_57_12186=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Severe extremity injury in the adult patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Jeremy W Cannon, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Todd E Rasmussen, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Heidi L Frankel, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12186/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/57/12186/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/57/12186/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1315120070\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trauma to the extremities represents one of the most common injury patterns seen in emergency medical and surgical practice. As extremity injuries are evaluated, each of four functional components (nerves, vessels, bones, and soft tissues) must be considered individually and together. If three of these four elements are injured, the patient has a &ldquo;mangled extremity&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/1\">",
"     1",
"    </a>",
"    ]. Achieving the best outcome in patients with severe extremity injuries requires a multidisciplinary approach with oversight by the general or trauma surgeon and commitment from other specialists including orthopedic, vascular, and plastic surgeons, as well as rehabilitation specialists. In most instances, limb salvage can be attempted even if the patient has a mangled extremity. However, at times, the injury to the extremity is so severe that primary amputation at the initial operation is required to save the patient&rsquo;s life.",
"   </p>",
"   <p>",
"    The initial management of severe extremity injury will be reviewed here. The management of minor extremity injuries, including isolated fracture management, is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43941?source=see_link\">",
"     \"General principles of fracture management: Bone healing and fracture description\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/42/6823?source=see_link\">",
"     \"General principles of fracture management: Early and late complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/58/17318?source=see_link\">",
"     \"General principles of acute fracture management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1400?source=see_link\">",
"     \"General principles of definitive fracture management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151199079\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of extremity injuries ranges widely from falls and motor vehicle collisions to blast and fragmentation injuries. The nature and severity of extremity injuries differs between the military and civilian setting. Military extremity injuries are primarily due to penetrating or combined mechanisms, which are associated with high rates of open fracture and vascular injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/2\">",
"     2",
"    </a>",
"    ]. In contrast, most severe extremity injuries in civilians are due to blunt trauma but about 12 percent of civilian extremity injures occur as a result of penetrating or combined mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1315120084\">",
"    <span class=\"h2\">",
"     Civilian",
"    </span>",
"    &nbsp;&mdash;&nbsp;Civilian extremity injuries occur most often due to falls (representing 50 to 60 percent of lower extremity injuries and 30 percent of upper extremity injuries), industrial or work-related accidents (up to 20 percent of upper extremity injuries), and motor vehicle crashes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/3\">",
"     3",
"    </a>",
"    ]. Most upper extremity injuries occur as a result of using machinery or tools.",
"   </p>",
"   <p>",
"    In civilians with nonfatal trauma, upper and lower extremity injuries are the most common reason for hospitalization, with more than one-third of those hospitalized having serious or limb-threatening injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1315120091\">",
"    <span class=\"h2\">",
"     Military",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 50 percent of the injuries recorded in the Joint Theater Trauma Registry involve the extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Many soldiers with extremity injuries also have other serious life-threatening injuries which complicate limb salvage [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/8\">",
"     8",
"    </a>",
"    ]. In one series, 25 percent had extremity injury associated with another serious nonextremity injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most extremity wounds during combat have a penetrating component, typically resulting from explosions (81 percent) or gunshot wounds (17 percent). Only 2 percent of extremity injuries during combat are due to isolated blunt trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/6\">",
"     6",
"    </a>",
"    ]. Because of the predominantly penetrating mechanism and war environment, many of these injuries involve multiple functional components (bone, nerve, vessel and soft-tissue damage), resulting in a high rate of mangled extremities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151205216\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2010, 236,952 lower extremity injuries and 189,600 upper extremity injuries were entered into the civilian National Trauma Data Bank (NTDB) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/4\">",
"     4",
"    </a>",
"    ]. Traumatic injury in civilians results in an estimated 3700 major amputations annually [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/3,9\">",
"     3,9",
"    </a>",
"    ]. The contemporary incidence of extremity injuries during combat is lower than in previous recorded conflicts representing about 50 percent of injuries, compared with about 59 percent during World War II, 60.2 percent during the Korean War, and 61.1 percent in the Vietnam War [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of an open fracture significantly increases the risk of osteomyelitis and, ultimately, limb loss depending upon the severity of injury to the associated soft tissues. Open fractures occur in approximately 3 percent of long bone fractures for an annual incidence of between 11.5 and 13 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The long bone that is most commonly involved in open fracture is the tibia. In one study, 24 percent of tibial fractures were open [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/12\">",
"     12",
"    </a>",
"    ]. High-energy motor vehicle collisions were responsible for 58 percent of these injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Associated vascular injuries occur in &lt;1 percent of all civilian fractures, (0.4 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/13\">",
"     13",
"    </a>",
"    ]. The risk of vascular injury increases with increasing injury severity. In retrospective reviews, the incidence of vascular injury was cited at 5 percent for severe fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/10\">",
"     10",
"    </a>",
"    ], and 6.6 percent for penetrating extremity injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/14\">",
"     14",
"    </a>",
"    ]. Among patients with arterial injury, bony injuries were present in 43 percent of patients, in a five-year retrospective review [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/15\">",
"     15",
"    </a>",
"    ]. Venous injuries occurred in 20 percent of the patients studied.",
"   </p>",
"   <p>",
"    The presence of a vascular injury also increases the risk for limb loss. In a contemporary combat review (2002 to 2009), 1570 patients with vascular injuries were identified out of 13,076 casualties (12 percent). Of these, 79 percent involved the upper and lower extremities. Isolated extremity arterial injuries were documented in 63 percent, isolated extremity venous injuries in 15 percent, and combined arterial and venous injuries in 22 percent. Rates of vascular injury in prior conflicts ranged from 1 percent in World War II to 2 to 3 percent in Korea and Vietnam [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122605634\">",
"    <span class=\"h1\">",
"     EXTREMITY ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knowledge of extremity anatomy and functional physiology is important for proper preoperative and postoperative extremity assessment. The anatomy of the upper and lower extremity is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909587619#H909587619\">",
"     \"Surgical management of severe extremity injury\", section on 'Extremity anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122605471\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform initial resuscitation, diagnostic evaluation, and management of the trauma patient with blunt or penetrating trauma based upon protocols from the Advanced Trauma Life Support (ATLS) program, established by the American College of Surgeons Committee on Trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/17\">",
"     17",
"    </a>",
"    ]. The initial resuscitation and evaluation of the patient with blunt or penetrating abdominal or thoracic trauma is discussed in detail elsewhere. Resuscitation and management of life-threatening thoracic or abdominal injury takes precedence over the extremity injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link\">",
"     \"Initial evaluation and management of blunt thoracic trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/21/23898?source=see_link\">",
"     \"Initial evaluation and management of penetrating thoracic trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151199357\">",
"    <span class=\"h2\">",
"     Control of hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;External bleeding from the extremity, and particularly bleeding from the junctional segment of the extremity vasculature (ie, axillary artery, common femoral artery), is life-threatening and should be controlled as soon as possible.",
"   </p>",
"   <p>",
"    Bleeding from extremity vascular injury can usually be controlled using direct pressure. However, because prolonged application of direct pressure, particularly bleeding from junctional vessels, is not practical during transport in the prehospital or tactical environment, other approaches have been used including topical agents, external compression clamps, and endovascular occlusion devices. These methods are not widely accepted in mainstream civilian clinical practice and have not been endorsed by the American College of Surgeons in the current version of the Advanced Trauma Life Support (ATLS) curriculum [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=see_link&amp;anchor=H13#H13\">",
"     \"Prehospital care of the adult trauma patient\", section on 'Hemorrhage control'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bleeding can also be controlled using a tourniquet, or direct clamping of visible vessels. Clamping vessels that cannot be clearly identified should",
"    <strong>",
"     not",
"    </strong>",
"    be performed. Pneumatic tourniquets are commonly used to lessen bleeding during the course of upper and lower extremity surgery. Although there is renewed interest in the civilian community in the use of tourniquets for control of extremity hemorrhage, civilian institutions have not uniformly endorsed their use [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=see_link&amp;anchor=H13#H13\">",
"     \"Prehospital care of the adult trauma patient\", section on 'Hemorrhage control'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variety of tourniquets have been developed to manage combat-related extremity hemorrhage with a low risk of ischemia and neurologic complications [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. The Combat Application Tourniquet (CAT), Emergency and Medical Tourniquet (EMT), and Special Operations Forces Tactical Tourniquet (SOFTT) meet the effectiveness standard of the United States military and occlude distal flow in &gt;80 percent of subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. The relative effectiveness of these tourniquets has been evaluated in human volunteers with each shown to attenuate the distal arterial pulse in upper and lower extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/22\">",
"     22",
"    </a>",
"    ]. The benefits of tourniquet application are illustrated in the following studies in combat casualty populations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study that evaluated 165 patients, 67 of whom had a prehospital tourniquet applied, control of bleeding was significantly improved with tourniquet application versus no tourniquet (83.3 versus 60.7 percent), and there were no differences in secondary amputation rates [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A prospective study of 232 combat casualties found a significantly improved survival rate (77 percent versus 0 percent) when using a tourniquet (prehospital or emergency department) versus no tourniquet [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/21\">",
"       21",
"      </a>",
"      ]. In this study, no amputations were required due to tourniquet use, but four transient nerve palsies were reported.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235775549\">",
"    <span class=\"h2\">",
"     Extremity radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with any of the following findings on primary trauma survey should undergo plain radiographs. Radiographic assessment should focus on the area of abnormality to include a joint above and below the potential injury, and the study should be performed with two projections (eg, anterior-posterior and lateral).",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extremity deformity",
"     </li>",
"     <li>",
"      Point tenderness",
"     </li>",
"     <li>",
"      Ecchymosis &nbsp;",
"     </li>",
"     <li>",
"      Laceration deep to the muscle fascia",
"     </li>",
"     <li>",
"      Laceration in proximity to a joint",
"     </li>",
"     <li>",
"      Joint laxity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bony injuries, particularly comminuted fractures, increase the risk of concomitant arterial injury (",
"    <a class=\"graphic graphic_table graphicRef61068 \" href=\"UTD.htm?7/13/7388\">",
"     table 1",
"    </a>",
"    ) and include fractures of the proximal humerus, humeral shaft (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71015 \" href=\"UTD.htm?33/12/33984\">",
"     image 1",
"    </a>",
"    ), distal radius or ulna, mid-femur (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78804 \" href=\"UTD.htm?21/13/21727\">",
"     image 2",
"    </a>",
"    ), and mid- or distal tibia-fibula fractures (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63393 \" href=\"UTD.htm?38/30/39394\">",
"     image 3",
"    </a>",
"    ). The presence of these fractures on radiographic survey should prompt full vascular assessment. (See",
"    <a class=\"local\" href=\"#H151204867\">",
"     'Vascular assessment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235775570\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic antibiotics should be started at the time of the diagnosis of open fracture. The open fracture site should be cleaned of any foreign debris and dressed with a moist sterile dressing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10646?source=see_link\">",
"     \"Treatment and prevention of osteomyelitis following trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235782137\">",
"    <span class=\"h2\">",
"     Tetanus prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tetanus prophylaxis should be given according to the Centers for Disease Control (CDC) guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=see_link&amp;anchor=H7#H7\">",
"     \"Tetanus-diphtheria toxoid vaccination in adults\", section on 'Immunization for patients with injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235777509\">",
"    <span class=\"h2\">",
"     Special situations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical scenarios involving extremity injury require specific management. These include traumatic amputation and electrical injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235777579\">",
"    <span class=\"h3\">",
"     Traumatic amputation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic amputation refers to limb loss that occurs in the field at the time of the initial trauma and is a special form of the mangled extremity. It is distinguished from primary amputation, which is removal of the limb during initial operative management, and secondary amputation, which is removal of the limb following attempted limb salvage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909592820#H909592820\">",
"     \"Surgical management of severe extremity injury\", section on 'Limb salvage versus amputation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Upper or lower limb replantation may be possible if the distal detached extremity is relatively uninjured [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Replantation is performed more commonly for traumatic upper extremity amputations. In the lower extremity, lower extremity prosthesis provides a good functional outcome that, in some cases, may be superior to that achieved with replantation.",
"   </p>",
"   <p>",
"    Warm ischemia time should be limited by wrapping the amputated body part in saline-soaked gauze or by indirect cooling (placing the body part in a container and then placing the container on ice). The extremity should",
"    <strong>",
"     not",
"    </strong>",
"    be exposed directly to ice.",
"   </p>",
"   <p>",
"    A multidisciplinary decision for replantation is made at the receiving facility with input from the trauma surgeon overseeing the patient&rsquo;s care, taking into consideration the patient&rsquo;s other injuries, and with input from subspecialists in orthopedic, plastic, and vascular surgery regarding feasibility of replantation and likely projected outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235777593\">",
"    <span class=\"h3\">",
"     Extremity electrical injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The upper extremity is commonly involved in electrical injuries which can result in significant soft tissue damage. These injuries are stratified into two groups based upon the voltage involved: low voltage (ie, &lt;1000 volts) and high voltage (&ge;1000 volts). The epidemiology, diagnosis, and general issues of the treatment of electrical injuries are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4410?source=see_link\">",
"     \"Environmental electrical injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Soft tissue damage occurring between the entrance and exit wounds can be substantial with high-voltage injuries. Amputation is necessary in up to 40 percent of these cases, which is not surprising given the large volume of soft tissue loss [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/27\">",
"     27",
"    </a>",
"    ]. The involved soft tissues should closely monitored for necrosis and vascular thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/28\">",
"     28",
"    </a>",
"    ]. Reconstruction can be undertaken once the full extent of soft tissue injury has manifested.",
"   </p>",
"   <p>",
"    Compartment syndrome should be anticipated with high voltage injuries and early fasciotomy should be performed as indicated. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/3/35897?source=see_link\">",
"     \"Lower extremity fasciotomy techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3400?source=see_link\">",
"     \"Patient management following extremity fasciotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122605572\">",
"    <span class=\"h1\">",
"     EXTREMITY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A brief extremity exam is performed during the initial trauma assessment (primary survey) but should be repeated in more detail once life-threatening injuries have been addressed and any active external bleeding is controlled. The extremity evaluation should proceed in an orderly fashion using the four functional elements of the extremity as a framework, which includes assessment of the nerves, vessels, bones, and soft tissues. Neurovascular injury is assumed until it is excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151204860\">",
"    <span class=\"h2\">",
"     Peripheral nerve assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neurologic exam in alert, cooperative patients should easily identify associated motor or sensory deficits. In the unconscious or uncooperative patient, gross deficits should be noted, such as a lack of movement in all or part of an extremity, or asymmetric movements. Detailed ongoing extremity evaluation should be performed as the patient&rsquo;s neurologic status improves to identify specific deficits referable to peripheral nerve injury.",
"   </p>",
"   <p>",
"    In the lower extremity, function of the femoral, sciatic, tibial, and peroneal nerves should be assessed since these nerves are more likely to be directly injured or affected by ischemia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Injury to the sciatic nerve results in decreased sensation on the medial thigh and weakness of hip flexion.",
"     </li>",
"     <li>",
"      Injury to the femoral nerve causes decreased sensation in the lateral thigh and leg, weakness of hip extension, and loss of motor function of the leg and foot.",
"     </li>",
"     <li>",
"      Deep peroneal nerve injury causes decreased sensation in the first dorsal webspace and causes foot drop.",
"     </li>",
"     <li>",
"      Injury to the tibial nerve results in loss of sensation to the heel, inability to plantar flex the foot, and cavus deformity of the foot.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although lack of plantar sensation has historically been taught as determining that a lower extremity is nonviable, subsequent data have found that this is",
"    <strong>",
"     not",
"    </strong>",
"    a reliable physical finding because patients with an insensate foot on initial exam can subsequently regain function [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909587626#H909587626\">",
"     \"Surgical management of severe extremity injury\", section on 'Lower extremity anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the upper extremity, the axillary nerve, radial nerve, and median nerve are all vulnerable to injury given their anatomic course. The game of &ldquo;rock, paper, scissors&rdquo; is a quick way to assess the motor function of the median, radial, and ulnar nerves, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909587640#H909587640\">",
"     \"Surgical management of severe extremity injury\", section on 'Upper extremity anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Injury to the axillary nerve (proximal humerus fractures) results in loss of arm abduction and an area of numbness or paresthesia along the lateral aspect of the upper arm.",
"     </li>",
"     <li>",
"      Radial nerve injury leads to loss of sensation on the dorsum of the hand and weakness of the wrist and finger extensors.",
"     </li>",
"     <li>",
"      Injury to the median nerve leads to decreased sensation on the palmar aspect of the first three digits and weakness of the thenar musculature.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151204867\">",
"    <span class=\"h2\">",
"     Vascular assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed vascular assessment of the injured extremity begins with a complete pulse examination (common femoral, popliteal, dorsalis pedis and posterior tibial arteries, axillary, brachial, radial, ulnar arteries) to identify asymmetry of pulses or the absence of palpable pulses. Auscultation over the injury site may reveal a bruit that may be indicative of a partially thrombosed or compressed vessel. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909587626#H909587626\">",
"     \"Surgical management of severe extremity injury\", section on 'Lower extremity anatomy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909587640#H909587640\">",
"     \"Surgical management of severe extremity injury\", section on 'Upper extremity anatomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the setting of a shock or the presence of joint dislocation or angulated fracture, the pulse assessment should be repeated after resuscitation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    reduction of the abnormality. In a study of combat injuries, 74 percent of patients who had no pulses on initial examination had reestablished blood flow to the foot following resuscitation and limb stabilization [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151207128\">",
"    <span class=\"h3\">",
"     Hard signs of arterial injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hard signs of vascular injury include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Active hemorrhage",
"     </li>",
"     <li>",
"      Expanding or pulsatile hematoma",
"     </li>",
"     <li>",
"      Bruit or thrill over wound",
"     </li>",
"     <li>",
"      Absent distal pulses",
"     </li>",
"     <li>",
"      Extremity ischemia (pain, pallor, paralysis, cool to touch)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a large observation study of penetrating extremity trauma, the presence of a hard sign of arterial injury was nearly 100 percent predictive of a vascular injury warranting surgical repair [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/14\">",
"     14",
"    </a>",
"    ]. These patients should be taken directly to the operating room where the injury can be surgically explored. If arteriography is needed to clarify arterial anatomy, it can be performed intraoperatively. &nbsp;",
"   </p>",
"   <p>",
"    With blunt trauma, hard signs are less reliable and false positives are common. Repeat physical examination after resuscitation, warming, and reduction of any orthopedic injuries should be performed. If a diminished pulse or other signs of vascular injury persist in the hemodynamically stable patient with blunt extremity injury, angiography should be performed to further delineate the location and nature of the injury. (See",
"    <a class=\"local\" href=\"#H235776174\">",
"     'Arteriography'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151207135\">",
"    <span class=\"h3\">",
"     Injured extremity index",
"    </span>",
"    &nbsp;&mdash;&nbsp;The injured extremity index (IEI) or arterial pressure index (API) is analogous to the ankle-brachial index (ABI) and should be performed in any patient who does not have hard signs of vascular injury. The term &ldquo;injured extremity index&rdquo; is a trauma-specific term that is broader and can be applied to the upper or lower extremity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10506?source=see_link&amp;anchor=H58544655#H58544655\">",
"     \"Noninvasive diagnosis of arterial disease\", section on 'Ankle-brachial index'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The IEI is the ratio of the highest systolic occlusion pressure in the injured extremity at the level of the dorsalis",
"    <span class=\"nowrap\">",
"     pedis/posterior",
"    </span>",
"    tibial (or",
"    <span class=\"nowrap\">",
"     radial/ulnar",
"    </span>",
"    arteries) divided by the systolic pressure in a proximal vessel in an uninjured extremity (most often the brachial artery). As an example, for an injured upper extremity, the higher value of the radial or ulnar occlusion pressure in the injured extremity would be divided by the occlusion pressure of the contralateral brachial artery.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A normal IEI (ie, &gt;0.9) has a high negative predictive value for vascular injury, allowing the patient to be observed or managed",
"      <strong>",
"       without",
"      </strong>",
"      immediate vascular imaging [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/32,33\">",
"       32,33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An IEI that is abnormal (ie, &le;0.9) may indicate an occult vascular injury. For patients who are hypothermic or hypotensive during the initial assessment, the IEI should be repeated 10 to 15 minutes after resuscitation and warming. An IEI that is persistently below 0.9 is predictive of vascular injury that requires additional vascular evaluation [",
"      <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/32,33\">",
"       32,33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnostic approach for patients with an IEI &le;0.9 should be within the context of the patient&rsquo;s overall clinical status and other associated injuries. In patients with multiple injuries who require head, torso, and abdominal computed tomography (CT), adding extremity CT angiography is a rational choice. The information obtained with respect to the extremity (positive or negative) assists the trauma surgeon in determining which injuries to manage first.",
"   </p>",
"   <p>",
"    For isolated extremity injuries or injuries with less complex associated injuries, the approach should be more individualized. Some patients may benefit from immediate surgical exploration and others from digital subtraction arteriography (DSA) rather than CT angiography. Every effort should be made to avoid an algorithm that exposes the patient to excessive radiation and intravenous contrast load such as CT angiography followed by DSA, which usually occurs in the context of seeking to better define an &lsquo;indiscriminate&rsquo; finding on CT angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/34\">",
"     34",
"    </a>",
"    ]. Consultation with a vascular surgeon can help aid with decision-making.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235776174\">",
"    <span class=\"h3\">",
"     Arteriography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arteriography, which can be accomplished using computed tomographic (CT) or conventional digital subtraction angiography (DSA), may be necessary to exclude vascular injury in hemodynamically stable patients with clinical signs consistent with potential vascular injury, such as an equivocal pulse examination, persistently diminished injured extremity index (IEI) in spite of resuscitation, and posterior knee dislocation. (See",
"    <a class=\"local\" href=\"#H151207135\">",
"     'Injured extremity index'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The need for vascular repair (open or endovascular) should be determined in the context of clinical findings in conjunction with an arteriographic study that shows a vascular injury. The clinical findings also establish the timing or urgency of the operation. In the context of a clinical examination, the following findings on arteriography (CT or DSA) strongly indicate the need for exploration and vascular repair. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909588599#H909588599\">",
"     \"Surgical management of severe extremity injury\", section on 'Revascularization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extravasation of contrast or pseudoaneurysm",
"     </li>",
"     <li>",
"      Arteriovenous fistula",
"     </li>",
"     <li>",
"      Flow-limiting intimal flap (flow-limiting based upon clinical exam). If the injured extremity index is normal, any observed flap is not considered to be flow-limiting.",
"     </li>",
"     <li>",
"      Occlusion of axial extremity arteries",
"     </li>",
"     <li>",
"      Distal embolism (may occur even in the presence of a relatively minor proximal injury)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The high sensitivity and speed of modern CT makes it attractive as a noninvasive study to identify and characterize suspected vascular injury. To obtain optimal images, contrast injection should be performed remote from the extremity of interest. In upper extremity exams, the arms should be raised above the head [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/35\">",
"     35",
"    </a>",
"    ]. The sensitivity of helical CT angiography with three-dimensional reconstruction ranges from 90 to 100 percent, with specificities &gt;99 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Interobserver agreement is about 90 percent. Newer generation multidetector scanners (16- or 64-slice) have sensitivity and specificity approaching 100 percent for clinically significant injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. In one study, multidetector CT angiography adequately imaged the extremity vasculature in spite of the artifact caused by orthopedic hardware and retained fragments [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/40\">",
"     40",
"    </a>",
"    ]. Three-dimensional reconstruction is not an absolute requirement with higher slice scanners. We use a 64-slice scanner without reconstruction, but consider it ideal to have the trauma or vascular surgeon review the cross-sectional images together with the radiologist.",
"   </p>",
"   <p>",
"    CT angiography is often preferred in patients with multiple trauma because it is less invasive than conventional arteriography and can be performed at the same time as head, chest, or abdominal CT, which are frequently needed in trauma patients. As a single study, computed tomographic (CT) angiography is less expensive than conventional arteriography [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/39\">",
"     39",
"    </a>",
"    ]. However, the cost of additional studies to sort out nondiagnostic findings on CT angiography and the cost of unnecessary surgical explorations or other interventions based upon the results of CT angiography need to be taken into account. As an example, in a study of 132 patients with penetrating trauma, 59 patients underwent CT angiography of which 28 were performed as a completion of a",
"    <span class=\"nowrap\">",
"     head/chest/abdominal",
"    </span>",
"    series, and 31 were for isolated extremity injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/34\">",
"     34",
"    </a>",
"    ]. Ten percent of the studies were indeterminate with two of these patients requiring exploration. There was no difference in the rate of indeterminate studies between whole body studies and those done for isolated extremity injury.",
"   </p>",
"   <p>",
"    Conventional digital subtraction arteriography (DSA) may be preferred initially in some patients, and can be performed in a dedicated interventional suite or in the operating room. Arteriography in the operating room has the advantage of eliminating unnecessary patient transport. A hybrid operating room (operating suite with interventional capabilities) is ideal but not necessary. Intraoperative arteriography can be performed using a portable power injector and portable digital subtraction arteriography, which are generally available in the operating room at civilian and military hospitals [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151204470\">",
"    <span class=\"h2\">",
"     Assessing soft tissue and bone",
"    </span>",
"    &nbsp;&mdash;&nbsp;The soft tissue envelope of muscle, subcutaneous fat, and skin should be evaluated for signs that indicate a potential underlying fracture, and to assess the severity of soft tissue damage, which is important for determining the potential risk of limb loss.",
"   </p>",
"   <p>",
"    The soft tissue injury should identify areas of missile entry and exit, soft tissue avulsion, skin or muscle flap formation, and evidence of contamination. In penetrating injuries, such as high velocity gunshot wounds or fragmentation injuries, the external wound may be relatively small; however, underlying soft tissue destruction can be significant. Severe or extensive muscle tissue damage can lead to rhabdomyolysis, independent of other risk factors such as ischemia-reperfusion or acute compartment syndrome. The diagnosis and management of rhabdomyolysis is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909590760#H909590760\">",
"     \"Surgical management of severe extremity injury\", section on 'Rhabdomyolysis and myoglobinuria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lacerations should be assessed for proximity to fracture sites and joint spaces. Most traumatic arthrotomies occur in the knee. Penetrating extremity injuries with suspected joint space involvement (traumatic arthrotomy) can be further evaluated by injecting the joint with saline. During the injection, the joint should be assessed to identify any distension, and the associated wound or laceration evaluated for fluid extravasation. Available studies indicate that between 155 and 194 mL of saline needs to be injected to achieve 95 percent sensitivity for identifying traumatic arthrotomy of the knee [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23368?source=see_link\">",
"     \"Joint aspiration or injection in adults: Technique and indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The muscle compartments of the affected extremity should also be evaluated on initial exam. Soft tissue injury and swelling can result in compartment syndrome. The lower extremity is more prone to compartment syndrome compared with the upper extremity because of its greater muscle mass and possibly because of its dependent position. The diagnosis and management of compartment syndrome are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=see_link\">",
"     \"Acute compartment syndrome of the extremities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/3/35897?source=see_link\">",
"     \"Lower extremity fasciotomy techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3400?source=see_link\">",
"     \"Patient management following extremity fasciotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Extremity deformity, point tenderness, ecchymosis, laceration deep to the muscle fascia, laceration near a joint, and joint laxity are signs of a potential fracture. Plain radiography should be performed to establish a diagnosis. (See",
"    <a class=\"local\" href=\"#H235775549\">",
"     'Extremity radiography'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Detailed discussions of specific fractures are found in separate topic reviews:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hip and thigh &ndash; (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/31/18937?source=see_link\">",
"       \"Hip fractures in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41960?source=see_link\">",
"       \"Midshaft femur fractures in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Leg and ankle &ndash; (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5957?source=see_link\">",
"       \"Proximal tibial fractures in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/4/30790?source=see_link\">",
"       \"Tibial shaft fractures in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36376?source=see_link\">",
"       \"Overview of ankle fractures in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arm &ndash; (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29543?source=see_link\">",
"       \"Proximal humeral fractures in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/55/27510?source=see_link\">",
"       \"Midshaft humeral fractures in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Forearm &ndash; (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/4/32838?source=see_link\">",
"       \"Radial head and neck fractures in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/13/21722?source=see_link\">",
"       \"Distal radius fractures in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An open fracture is defined as a bony fracture and soft tissue laceration that are in communication with each other (",
"    <a class=\"graphic graphic_picture graphicRef59761 \" href=\"UTD.htm?20/22/20837\">",
"     picture 1",
"    </a>",
"    ). Open fractures occur in up to 24 percent of tibia fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In a review of 1281 soldiers with extremity injuries, 915 fractures were identified of which 82 percent were open [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/44\">",
"     44",
"    </a>",
"    ]. Open fracture significantly increases the risk of osteomyelitis and ultimately limb loss depending upon the severity of the associated soft tissue injury. (See",
"    <a class=\"local\" href=\"#H151204170\">",
"     'Open fracture grading'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909590746#H909590746\">",
"     \"Surgical management of severe extremity injury\", section on 'Wound complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Following the initial assessment, the affected bone(s) should be aligned as well as possible and stabilized with a splint or traction to minimize soft tissue injury and to optimize distal perfusion. Open wounds should be irrigated with saline to eliminate gross contamination prior to the application of temporary gauze dressings. The patient can then undergo further diagnostic workup for associated injuries. Techniques for splinting musculoskeletal injuries are discussed in elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=see_link\">",
"     \"Splinting of musculoskeletal injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Posterior knee dislocation is associated with popliteal artery injury, and a careful vascular examination should be performed when this injury is identified. Following reduction of the dislocation, the vascular examination should be repeated and, if normal, the patient should continue to be observed. If the pulses remain abnormal, vascular imaging is indicated (arteriography) and management depends upon the findings (",
"    <a class=\"graphic graphic_algorithm graphicRef72754 \" href=\"UTD.htm?24/46/25327\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38038?source=see_link\">",
"     \"Knee (tibiofemoral) dislocation and reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122608471\">",
"    <span class=\"h1\">",
"     INJURY SEVERITY SCORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following examination of the extremity, overall injury severity should be assessed to determine whether a primary amputation should be performed, of if the limb is potentially salvageable. The utility of using injury severity scores in predicting the success of limb salvage is discussed elsewhere. (See",
"    <a class=\"local\" href=\"#H235778360\">",
"     'Predicting limb loss'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Various extremity injury severity scores are described, including the Mangled Extremity Severity Score (MESS); the Limb Salvage Index (LSI); the Predictive Salvage Index (PSI); the Nerve Injury, Ischemia, Soft-Tissue Injury, Skeletal Injury, Shock, and Age of Patient Score (NISSSA); the Hannover Fracture Scale-97 (HFS-97) and the Gustilo-Anderson open fracture grading system [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/1,45-49\">",
"     1,45-49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151203483\">",
"    <span class=\"h2\">",
"     MESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Mangled Extremity Severity Score (MESS) is the most widely applied scoring system to categorize the degree of extremity injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/1\">",
"     1",
"    </a>",
"    ]. The term &ldquo;mangled&rdquo; refers to a limb in which at least three of the four functional components (bone, vessels, nerves, and soft tissue) are injured.",
"   </p>",
"   <p>",
"    The MESS is calculated by scoring each of the areas listed below (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?15/54/16225?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). Component scores are then added to yield the MESS which ranges from 2 to 14. &ldquo;Severity and duration of ischemia&rdquo; scores are doubled if perfusion has not been restored within six hours of injury.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Severity of skeletal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      soft tissue injury",
"     </li>",
"     <li>",
"      Severity and duration of limb ischemia",
"     </li>",
"     <li>",
"      Severity of shock",
"     </li>",
"     <li>",
"      Patient age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151204170\">",
"    <span class=\"h2\">",
"     Open fracture grading",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open fractures should be graded using the Gustilo-Anderson system, which is usually performed intraoperatively; however, the severity of the orthopedic injury can generally be established at the time of extremity evaluation. An increasing grade of open fracture has been correlated to an increased risk of infection and increased rate of amputation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. A disadvantage of this scoring system is the low interobserver agreement of 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type I &ndash; Wound &lt;1 cm; minimal contamination, comminution, or soft tissue damage",
"     </li>",
"     <li>",
"      Type II &ndash; Wound &gt;1cm; moderate soft tissue damage; minimal periosteal stripping",
"     </li>",
"     <li>",
"      Type IIIA &ndash; Severe soft tissue damage and substantial contamination; soft tissue coverage adequate",
"     </li>",
"     <li>",
"      Type IIIB &ndash; Severe soft tissue damage and substantial contamination; soft tissue coverage inadequate",
"     </li>",
"     <li>",
"      Type IIIC &ndash; Open fracture with an associated arterial injury requiring repair",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Orthopaedic Trauma Association has recently proposed a framework for developing a new classification scheme for open fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/49\">",
"     49",
"    </a>",
"    ]. Over time, this descriptive framework may replace the Gustillo-Anderson system, but it has yet to be validated and correlated with complications and outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122607470\">",
"    <span class=\"h1\">",
"     MANAGEMENT APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once a severe extremity injury has been identified, a management plan should be developed taking into consideration the patient&rsquo;s other injuries. In multiple trauma patients, the management plan should be made by one lead surgeon in collaboration with the orthopedic, vascular, and neurosurgery services, as needed. The priority of each injury, and timing and approach to each injury, should be determined in advance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909593032\">",
"    <span class=\"h2\">",
"     Hemodynamically unstable",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon ATLS principles, the hemodynamically unstable trauma patient with indications for surgery (eg, positive Focused Assessment with Sonography for Trauma [FAST], hard signs of vascular injury) should be taken to the operating room to identify and control bleeding. Life-threatening injuries to the neck, chest, or abdomen take precedence over the extremity injury. A damage control or staged approach to the injured extremity is warranted once external bleeding from the extremity is controlled. In some cases, the severity of the extremity injury or time constraints due to the need to manage life-threatening injuries will preclude meaningful attempts at limb salvage and primary amputation may be the best option. If the extremity is the primary (or only) injury, a more definitive approach to repair can be taken at the outset. (See",
"    <a class=\"local\" href=\"#H151207128\">",
"     'Hard signs of arterial injury'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909588550#H909588550\">",
"     \"Surgical management of severe extremity injury\", section on 'Damage control surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909593039\">",
"    <span class=\"h2\">",
"     Hemodynamically stable with vascular injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;For hemodynamically stable patients, the timing of the management of extremity injury when vascular injury is present depends upon the degree and duration of ischemia. Patients with hard signs of vascular injury should be taken immediately to the operating room for evaluation and management. Patients with clinical signs of arterial injury, including an injured extremity index (IEI) &lt;0.9, should be evaluated using computed tomographic (CT) angiography or conventional arteriography depending upon institutional resources. In the presence of bony instability, arterial revascularization is fraught with difficulties. Under these circumstances, arterial shunting, if needed, and fracture stabilization followed by definitive vascular repair once the bones have been stabilized may be the most appropriate sequence of care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909588599#H909588599\">",
"     \"Surgical management of severe extremity injury\", section on 'Revascularization'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909588578#H909588578\">",
"     \"Surgical management of severe extremity injury\", section on 'Fracture management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H909593054\">",
"    <span class=\"h2\">",
"     Hemodynamically stable without vascular injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;The timing and management of extremity injury when no vascular injury is present depends upon the severity of fracture and the degree of soft tissue loss. Open fracture debridement and fracture stabilization should be performed as soon as feasible depending upon the nature and extent of nonextremity injuries. Multiple debridement procedures are frequently required before definitive fracture fixation and soft tissue coverage can be achieved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909588627#H909588627\">",
"     \"Surgical management of severe extremity injury\", section on 'Soft tissue debridement/coverage'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909588578#H909588578\">",
"     \"Surgical management of severe extremity injury\", section on 'Fracture management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235778360\">",
"    <span class=\"h2\">",
"     Predicting limb loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;The likelihood that extremity injury will result in limb loss can be estimated based upon clinical findings with the aid of scoring systems. No injury severity scoring system has been found to be sufficiently sensitive for determining whether efforts at limb salvage will fail; however, determining the factors that may influence outcome may be helpful when counseling the patient (or family members) about options for treatment, and may guide a decision for primary amputation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909592820#H909592820\">",
"     \"Surgical management of severe extremity injury\", section on 'Limb salvage versus amputation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235778415\">",
"    <span class=\"h3\">",
"     Clinical predictors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some injuries are associated with high amputation rates in spite of best efforts at limb salvage. The risk of limb loss is the greatest for injuries with combined bony instability, vascular injury (particularly combined arterial and venous injury), and soft tissue injury. One example is posterior dislocation of the knee, which can present with severe ligamentous instability and injury to the popliteal artery and vein [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/50\">",
"     50",
"    </a>",
"    ]. High-energy and penetrating injuries can also lead to combined bony, vascular, and soft tissue injury [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines for the management of complex extremity injuries prepared by the American College of Surgeons Committee on Trauma ad hoc Committee on Outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/51\">",
"     51",
"    </a>",
"    ], supplemented by the Eastern Association for the Surgery of Trauma (EAST) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/52\">",
"     52",
"    </a>",
"    ], cite the following as factors that increase the risk for limb loss:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delay in revascularization",
"     </li>",
"     <li>",
"      Blunt trauma",
"     </li>",
"     <li>",
"      High-velocity penetrating trauma",
"     </li>",
"     <li>",
"      Lower extremity versus upper extremity vascular involvement (especially popliteal artery)",
"     </li>",
"     <li>",
"      Associated injuries",
"     </li>",
"     <li>",
"      Older age and older physiologic health",
"     </li>",
"     <li>",
"      Shock and obvious limb ischemia",
"     </li>",
"     <li>",
"      Forward combat zone",
"     </li>",
"     <li>",
"      Resource-limited environment",
"     </li>",
"     <li>",
"      Multicasualty event",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H235778422\">",
"    <span class=\"h3\">",
"     Scoring systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury severity scoring systems are widely applied but are not highly sensitive for predicting the need for amputation following extremity injury. (See",
"    <a class=\"local\" href=\"#H122608471\">",
"     'Injury severity scoring'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The MESS is limited in its ability to predict need for amputation, but is a commonly cited tool that provides a frame of reference for comparing extremity injuries in clinical studies. In the original study validating the Mangled Extremity Severity Score (MESS) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?15/54/16225?source=see_link\">",
"     calculator 1",
"    </a>",
"    ) as a predictor of limb loss, a MESS &ge;7 was 100 percent accurate for predicting amputation and a score &lt;7 predicted limb salvage in all cases.",
"    <sup>",
"    </sup>",
"    In this study, patients with peripheral nerve deficits were excluded, because they were assumed to all require amputation.",
"   </p>",
"   <p>",
"    Larger prospective trials with long-term follow-up have not successfully duplicated the results of the original MESS study [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. The Lower Extremity Assessment Program (LEAP) investigators evaluated 556 patients with lower extremity injuries using five injury severity scoring systems, including MESS [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/56\">",
"     56",
"    </a>",
"    ]. Each of the scoring systems were highly specific (0.84 to 0.98) but not sensitive (0.37 to 0.67) for predicting limb loss. Specifically, regarding the MESS, these authors found that a MESS of 7 had a sensitivity of 0.45 but a specificity of 0.93 for predicting amputation. Thus, the MESS is best used as one tool along with clinical exam and patient comorbidities to help in the decision for or against limb salvage. A low score suggests limb salvage potential; however, a high score does",
"    <strong>",
"     not",
"    </strong>",
"    reliably predict the need for eventual amputation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H151203162\">",
"    <span class=\"h1\">",
"     MORBIDITY AND MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe lower extremity injuries have a high incidence of complication, including wound complications (infection, necrosis, nonunion, osteomyelitis), venous thromboembolism, rhabdomyolysis, and late complications including amputation and heterotopic ossification in residual limbs. Most of these complications require or prolong hospitalization, or require additional operative treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/57\">",
"     57",
"    </a>",
"    ]. These complications are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909590739#H909590739\">",
"     \"Surgical management of severe extremity injury\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In blunt civilian extremity injury, mortality ranges from 5 to 10 percent and is greater with blunt compared with penetrating injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/15,58\">",
"     15,58",
"    </a>",
"    ]. Mortality correlates to the volume of blood lost as a result of the extremity injury, which can be significant with involving the junctional vasculature [",
"    <a class=\"abstract\" href=\"UTD.htm?11/57/12186/abstract/18\">",
"     18",
"    </a>",
"    ]. Higher mortality rates reflect more severe extremity injury, coexistent injury, and development of complications (eg, venous thromboembolism). Mortality rates are lowest for isolated extremity injuries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1315120252\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trauma to the extremities represents one of the most common injury patterns seen in emergency practice. Civilian extremity injuries are most commonly due to blunt mechanisms, whereas combat injuries are predominantly due to penetrating or mixed mechanisms. In combat, extremity injuries are present in half of all casualties. (See",
"      <a class=\"local\" href=\"#H1315120070\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H151205216\">",
"       'Incidence'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H151199079\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A brief extremity exam is performed during the initial trauma assessment (primary survey), but should be repeated once life-threatening injuries have been addressed. The extremity evaluation should be structured to assess the four functional components of the extremity (nerves, vessels, bones, soft tissues). Injury to three of these four elements constitutes a &ldquo;mangled extremity.&rdquo; Patients with extremity deformity, point tenderness, ecchymosis, deep laceration, laceration near a joint, or joint laxity should undergo plain radiographs to evaluate for extremity fracture. (See",
"      <a class=\"local\" href=\"#H122605471\">",
"       'Initial evaluation and management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients",
"      <strong>",
"       with",
"      </strong>",
"      hard signs of a vascular injury (eg, pulsatile bleeding, an expanding hematoma, distal ischemia) should be taken directly to the operating room for further examination and management. Direct pressure is usually effective in controlling extremity hemorrhage. For extremity hemorrhage that is not adequately controlled with direct pressure, we suggest placement of an extremity tourniquet (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Although not widely used for civilian injuries, military experience with prehospital and emergency department tourniquet application has shown that tourniquets save lives with a low rate of complications. (See",
"      <a class=\"local\" href=\"#H151199357\">",
"       'Control of hemorrhage'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=see_link&amp;anchor=H13#H13\">",
"       \"Prehospital care of the adult trauma patient\", section on 'Hemorrhage control'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients",
"      <strong>",
"       without",
"      </strong>",
"      hard signs of vascular injury, an injured extremity index (IEI) should be performed, which is analogous to the ankle-brachial index (ABI). An abnormal IEI (&lt;0.9) suggests the presence of a vascular injury. Hemodynamically stable patients with an abnormal IEI should undergo further imaging to exclude vascular injury. Arteriography is often performed using computed tomographic (CT) angiography, because it is less invasive than conventional arteriography; has high sensitivity and specificity; and can be performed at the same time as head, chest, or abdominal CT, which are frequently needed. Where an appropriately sensitive CT scanner is not immediately available, conventional arteriography can be performed to exclude vascular injury either in a dedicated interventional suite or in the operating room. (See",
"      <a class=\"local\" href=\"#H151207135\">",
"       'Injured extremity index'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H235776174\">",
"       'Arteriography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Every effort should be made to salvage the limb if there is no clear indication for primary amputation. An attempt to salvage a mangled extremity may also be reasonable, but severe injuries may require primary amputation to save the patient&rsquo;s life. Although clinical scoring systems can indicate when limb salvage is likely to be successful, these are not accurate for determining the need for emergent primary amputation. Following every initial limb salvage attempt, the extremity should be re-evaluated in the short term for signs of sensorimotor function and tissue viability. Factors that increase the risk of limb loss include lower extremity vascular injury, delayed revascularization, blunt or high-velocity mechanism, multiple additional injuries, advanced age and multiple comorbidities, shock and obvious limb ischemia, and a severe extremity injury sustained in a resource-limited environment or during a mass casualty event. (See",
"      <a class=\"local\" href=\"#H151203483\">",
"       'MESS'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H235778360\">",
"       'Predicting limb loss'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=see_link&amp;anchor=H909588599#H909588599\">",
"       \"Surgical management of severe extremity injury\", section on 'Revascularization'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/1\">",
"      Johansen K, Daines M, Howey T, et al. Objective criteria accurately predict amputation following lower extremity trauma. J Trauma 1990; 30:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/2\">",
"      Johnson BA, Carmack D, Neary M, et al. Operation Iraqi Freedom: the Landstuhl Regional Medical Center experience. J Foot Ankle Surg 2005; 44:177.",
"     </a>",
"    </li>",
"    <li>",
"     Mackenzie EJ, Fowler CJ. Epidemiology. In: Trauma, 6th ed., Feliciano DV, Mattox KL, Moore EE (Eds), McGraw-Hill Medical, New York 2008. p.25.",
"    </li>",
"    <li>",
"     Nathens AB. National Trauma Data Bank Annual Report. 2010.",
"    </li>",
"    <li>",
"     Finkelstein EA, Corso PS, Miller TR, et al. The incidence and economic burden of injuries in the United States, Oxford University Press, New York 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/6\">",
"      Owens BD, Kragh JF Jr, Wenke JC, et al. Combat wounds in operation Iraqi Freedom and operation Enduring Freedom. J Trauma 2008; 64:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/7\">",
"      Belmont PJ Jr, Goodman GP, Zacchilli M, et al. Incidence and epidemiology of combat injuries sustained during \"the surge\" portion of operation Iraqi Freedom by a U.S. Army brigade combat team. J Trauma 2010; 68:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/8\">",
"      Fox CJ, Gillespie DL, O'Donnell SD, et al. Contemporary management of wartime vascular trauma. J Vasc Surg 2005; 41:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/9\">",
"      Dillingham TR, Pezzin LE, MacKenzie EJ. Incidence, acute care length of stay, and discharge to rehabilitation of traumatic amputee patients: an epidemiologic study. Arch Phys Med Rehabil 1998; 79:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/10\">",
"      Meling T, Harboe K, S&oslash;reide K. Incidence of traumatic long-bone fractures requiring in-hospital management: a prospective age- and gender-specific analysis of 4890 fractures. Injury 2009; 40:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/11\">",
"      Court-Brown CM, Rimmer S, Prakash U, McQueen MM. The epidemiology of open long bone fractures. Injury 1998; 29:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/12\">",
"      Court-Brown CM, McBirnie J. The epidemiology of tibial fractures. J Bone Joint Surg Br 1995; 77:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/13\">",
"      Schlickewei W, Kuner EH, Mullaji AB, G&ouml;tze B. Upper and lower limb fractures with concomitant arterial injury. J Bone Joint Surg Br 1992; 74:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/14\">",
"      Frykberg ER, Dennis JW, Bishop K, et al. The reliability of physical examination in the evaluation of penetrating extremity trauma for vascular injury: results at one year. J Trauma 1991; 31:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/15\">",
"      Franz RW, Shah KJ, Halaharvi D, et al. A 5-year review of management of lower extremity arterial injuries at an urban level I trauma center. J Vasc Surg 2011; 53:1604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/16\">",
"      White JM, Stannard A, Burkhardt GE, et al. The epidemiology of vascular injury in the wars in Iraq and Afghanistan. Ann Surg 2011; 253:1184.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Surgeons Committee on Trauma (Ed). Advanced Trauma Life Support for Doctors, American College of Surgeons, Chicago, IL 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/18\">",
"      Dorlac WC, DeBakey ME, Holcomb JB, et al. Mortality from isolated civilian penetrating extremity injury. J Trauma 2005; 59:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/19\">",
"      Swan KG Jr, Wright DS, Barbagiovanni SS, et al. Tourniquets revisited. J Trauma 2009; 66:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/20\">",
"      Beekley AC, Sebesta JA, Blackbourne LH, et al. Prehospital tourniquet use in Operation Iraqi Freedom: effect on hemorrhage control and outcomes. J Trauma 2008; 64:S28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/21\">",
"      Kragh JF Jr, Walters TJ, Baer DG, et al. Survival with emergency tourniquet use to stop bleeding in major limb trauma. Ann Surg 2009; 249:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/22\">",
"      Walters TJ, Wenke JC, Kauvar DS, et al. Effectiveness of self-applied tourniquets in human volunteers. Prehosp Emerg Care 2005; 9:416.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services Centers for Disease Control and Prevention. Tetanus. www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf (Accessed on May 06, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/24\">",
"      MALT RA, MCKHANN C. REPLANTATION OF SEVERAL ARMS. JAMA 1964; 189:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/25\">",
"      Graham B, Adkins P, Tsai TM, et al. Major replantation versus revision amputation and prosthetic fitting in the upper extremity: a late functional outcomes study. J Hand Surg Am 1998; 23:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/26\">",
"      Ravindra KV, Buell JF, Kaufman CL, et al. Hand transplantation in the United States: experience with 3 patients. Surgery 2008; 144:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/27\">",
"      Cancio LC, Jimenez-Reyna JF, Barillo DJ, et al. One hundred ninety-five cases of high-voltage electric injury. J Burn Care Rehabil 2005; 26:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/28\">",
"      Herrera FA, Hassanein AH, Potenza B, et al. Bilateral upper extremity vascular injury as a result of a high-voltage electrical burn. Ann Vasc Surg 2010; 24:825.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/29\">",
"      Bosse MJ, McCarthy ML, Jones AL, et al. The insensate foot following severe lower extremity trauma: an indication for amputation? J Bone Joint Surg Am 2005; 87:2601.",
"     </a>",
"    </li>",
"    <li>",
"     Peterson SL, Lehman TP. Upper extremity injury. In: Trauma, 6th ed., Feliciano, DV, Mattox, KL, Moore, EE (Eds), McGraw-Hill Medical, New York  p.871.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/31\">",
"      Burkhardt GE, Cox M, Clouse WD, et al. Outcomes of selective tibial artery repair following combat-related extremity injury. J Vasc Surg 2010; 52:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/32\">",
"      Lynch K, Johansen K. Can Doppler pressure measurement replace \"exclusion\" arteriography in the diagnosis of occult extremity arterial trauma? Ann Surg 1991; 214:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/33\">",
"      Mills WJ, Barei DP, McNair P. The value of the ankle-brachial index for diagnosing arterial injury after knee dislocation: a prospective study. J Trauma 2004; 56:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/34\">",
"      Wallin D, Yaghoubian A, Rosing D, et al. Computed tomographic angiography as the primary diagnostic modality in penetrating lower extremity vascular injuries: a level I trauma experience. Ann Vasc Surg 2011; 25:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/35\">",
"      Uyeda JW, Anderson SW, Sakai O, Soto JA. CT angiography in trauma. Radiol Clin North Am 2010; 48:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/36\">",
"      Soto JA, M&uacute;nera F, Cardoso N, et al. Diagnostic performance of helical CT angiography in trauma to large arteries of the extremities. J Comput Assist Tomogr 1999; 23:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/37\">",
"      Soto JA, M&uacute;nera F, Morales C, et al. Focal arterial injuries of the proximal extremities: helical CT arteriography as the initial method of diagnosis. Radiology 2001; 218:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/38\">",
"      Melvin JS, Dombroski DG, Torbert JT, et al. Open tibial shaft fractures: I. Evaluation and initial wound management. J Am Acad Orthop Surg 2010; 18:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/39\">",
"      Seamon MJ, Smoger D, Torres DM, et al. A prospective validation of a current practice: the detection of extremity vascular injury with CT angiography. J Trauma 2009; 67:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/40\">",
"      White PW, Gillespie DL, Feurstein I, et al. Sixty-four slice multidetector computed tomographic angiography in the evaluation of vascular trauma. J Trauma 2010; 68:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/41\">",
"      Propper BW, Alley JB, Gifford SM, et al. Endovascular treatment of a blunt aortic injury in Iraq: extension of innovative endovascular capabilities to the modern battlefield. Ann Vasc Surg 2009; 23:687.e19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/42\">",
"      Nord RM, Quach T, Walsh M, et al. Detection of traumatic arthrotomy of the knee using the saline solution load test. J Bone Joint Surg Am 2009; 91:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/43\">",
"      Keese GR, Boody AR, Wongworawat MD, Jobe CM. The accuracy of the saline load test in the diagnosis of traumatic knee arthrotomies. J Orthop Trauma 2007; 21:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/44\">",
"      Owens BD, Kragh JF Jr, Macaitis J, et al. Characterization of extremity wounds in Operation Iraqi Freedom and Operation Enduring Freedom. J Orthop Trauma 2007; 21:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/45\">",
"      Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma 1984; 24:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/46\">",
"      Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am 1976; 58:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/47\">",
"      Okike K, Bhattacharyya T. Trends in the management of open fractures. A critical analysis. J Bone Joint Surg Am 2006; 88:2739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/48\">",
"      Brumback RJ, Jones AL. Interobserver agreement in the classification of open fractures of the tibia. The results of a survey of two hundred and forty-five orthopaedic surgeons. J Bone Joint Surg Am 1994; 76:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/49\">",
"      Orthopaedic Trauma Association: Open Fracture Study Group. A new classification scheme for open fractures. J Orthop Trauma 2010; 24:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/50\">",
"      Patterson BM, Agel J, Swiontkowski MF, et al. Knee dislocations with vascular injury: outcomes in the Lower Extremity Assessment Project (LEAP) Study. J Trauma 2007; 63:855.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Surgeons Committee on Trauma ad hoc Committee on Outcomes. Management of Complex Extremity Trauma. www.facs.org/trauma/publications/mancompexttrauma.pdf (Accessed on May 06, 2011).",
"    </li>",
"    <li>",
"     Arrillaga A, Bynoe R, Frykberg ER, Nagy K. EAST Practice Management Guidelines for  Penetrating Trauma to the Lower Extremity. file://www.east.org/Portal/Default.aspx?tabid=57 (Accessed on May 06, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/53\">",
"      Sohn VY, Arthurs ZM, Herbert GS, et al. Demographics, treatment, and early outcomes in penetrating vascular combat trauma. Arch Surg 2008; 143:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/54\">",
"      Jurkovich G, Mock C, MacKenzie E, et al. The Sickness Impact Profile as a tool to evaluate functional outcome in trauma patients. J Trauma 1995; 39:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/55\">",
"      Ly TV, Travison TG, Castillo RC, et al. Ability of lower-extremity injury severity scores to predict functional outcome after limb salvage. J Bone Joint Surg Am 2008; 90:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/56\">",
"      Bosse MJ, MacKenzie EJ, Kellam JF, et al. A prospective evaluation of the clinical utility of the lower-extremity injury-severity scores. J Bone Joint Surg Am 2001; 83-A:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/57\">",
"      Harris AM, Althausen PL, Kellam J, et al. Complications following limb-threatening lower extremity trauma. J Orthop Trauma 2009; 23:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/57/12186/abstract/58\">",
"      Rozycki GS, Tremblay LN, Feliciano DV, McClelland WB. Blunt vascular trauma in the extremity: diagnosis, management, and outcome. J Trauma 2003; 55:814.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15150 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-D60132E406-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12186=[""].join("\n");
var outline_f11_57_12186=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1315120252\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1315120070\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H151199079\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1315120084\">",
"      Civilian",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1315120091\">",
"      Military",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H151205216\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H122605634\">",
"      EXTREMITY ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H122605471\">",
"      INITIAL EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H151199357\">",
"      Control of hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H235775549\">",
"      Extremity radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H235775570\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H235782137\">",
"      Tetanus prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H235777509\">",
"      Special situations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H235777579\">",
"      - Traumatic amputation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H235777593\">",
"      - Extremity electrical injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H122605572\">",
"      EXTREMITY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H151204860\">",
"      Peripheral nerve assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H151204867\">",
"      Vascular assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H151207128\">",
"      - Hard signs of arterial injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H151207135\">",
"      - Injured extremity index",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H235776174\">",
"      - Arteriography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H151204470\">",
"      Assessing soft tissue and bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H122608471\">",
"      INJURY SEVERITY SCORING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H151203483\">",
"      MESS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H151204170\">",
"      Open fracture grading",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H122607470\">",
"      MANAGEMENT APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909593032\">",
"      Hemodynamically unstable",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909593039\">",
"      Hemodynamically stable with vascular injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H909593054\">",
"      Hemodynamically stable without vascular injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H235778360\">",
"      Predicting limb loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H235778415\">",
"      - Clinical predictors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H235778422\">",
"      - Scoring systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H151203162\">",
"      MORBIDITY AND MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1315120252\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15150\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15150|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?24/46/25327\" title=\"algorithm 1\">",
"      Management of knee dislocation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15150|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/12/33984\" title=\"diagnostic image 1\">",
"      Humerus fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/13/21727\" title=\"diagnostic image 2\">",
"      Comminuted femoral shaft fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/30/39394\" title=\"diagnostic image 3\">",
"      Tib-fib fracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15150|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/22/20837\" title=\"picture 1\">",
"      Open fracture of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15150|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/13/7388\" title=\"table 1\">",
"      Artery and nerve injuries associated with specific fractures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?15/54/16225?source=related_link\" title=\"calculator 1\">",
"      Calculator: Mangled Extremity Severity Score (MESS)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/57/8090?source=related_link\">",
"      Acute compartment syndrome of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/13/21722?source=related_link\">",
"      Distal radius fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4410?source=related_link\">",
"      Environmental electrical injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/58/17318?source=related_link\">",
"      General principles of acute fracture management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1400?source=related_link\">",
"      General principles of definitive fracture management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43941?source=related_link\">",
"      General principles of fracture management: Bone healing and fracture description",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/42/6823?source=related_link\">",
"      General principles of fracture management: Early and late complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/31/18937?source=related_link\">",
"      Hip fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/21/23898?source=related_link\">",
"      Initial evaluation and management of penetrating thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23368?source=related_link\">",
"      Joint aspiration or injection in adults: Technique and indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38038?source=related_link\">",
"      Knee (tibiofemoral) dislocation and reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/3/35897?source=related_link\">",
"      Lower extremity fasciotomy techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41960?source=related_link\">",
"      Midshaft femur fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/55/27510?source=related_link\">",
"      Midshaft humeral fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10506?source=related_link\">",
"      Noninvasive diagnosis of arterial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36376?source=related_link\">",
"      Overview of ankle fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3400?source=related_link\">",
"      Patient management following extremity fasciotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=related_link\">",
"      Prehospital care of the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29543?source=related_link\">",
"      Proximal humeral fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/52/5957?source=related_link\">",
"      Proximal tibial fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/4/32838?source=related_link\">",
"      Radial head and neck fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/40/19082?source=related_link\">",
"      Surgical management of severe extremity injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=related_link\">",
"      Tetanus-diphtheria toxoid vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/4/30790?source=related_link\">",
"      Tibial shaft fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10646?source=related_link\">",
"      Treatment and prevention of osteomyelitis following trauma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_57_12187="Criteria associated with RADS";
var content_f11_57_12187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for diagnosis of reactive airways dysfunction syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        A documented absence of previous respiratory complaints.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The onset of symptoms should occur after a single specific exposure.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The exposure should be to a gas, smoke, fume, or vapor with irritant qualities that was present in very high concentrations.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The onset of symptoms should occur within 24 hours of exposure and should persist for at least three months.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The symptoms should simulate asthma with cough, wheezing, and dyspnea.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary function tests may or may not show airflow obstruction.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methacholine challenge should be positive.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other types of pulmonary diseases should be ruled out.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Brooks, SM, Weiss, MA, Bernstein, IL, Chest 1985; 88:376.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12187=[""].join("\n");
var outline_f11_57_12187=null;
var title_f11_57_12188="Recs breast MRI screen";
var content_f11_57_12188=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACS recommendations for breast MRI screening as an adjunct to mammography",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Recommend annual MRI screening (based on high risk of breast cancer and high sensitivity of MRI*)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <em>",
"        BRCA",
"       </em>",
"       mutation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       First-degree relative of",
"       <em>",
"        BRCA",
"       </em>",
"       carrier, but untested",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lifetime risk &gt;20-25 percent or greater, as defined by BRCAPRO or other models that are largely dependent on family history",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Recommend annual MRI screening (based on high risk of breast cancer)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Radiation to chest between age 10 and 30 years",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Li-Fraumeni syndrome and first-degree relatives",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cowden and Bannayan-Riley-Ruvalcaba syndromes and first-degree relatives",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Insufficient evidence to recommend for or against MRI screening&Delta;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lifetime risk 15-20 percent, as defined by BRCAPRO or other models that are largely dependent on family history",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Atypical ductal hyperplasia (ADH)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heterogeneously or extremely dense breast on mammography",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Women with a personal history of breast cancer, including ductal carcinoma in situ (DCIS)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Recommend against MRI screening (based on expert consensus opinion)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Women at &lt;15 percent lifetime risk",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Evidence from nonrandomized screening trials and observational studies.",
"     <br>",
"      &Delta; Payment should not be a barrier. Screening decisions should be made on a case-by-case basis, as there may be particular factors to support MRI.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Saslow D, Boetes C, Burke W, et al. American Cancer Screening Guidelines for Breast Screening with MRI as an Adjunct to Mammography. CA Cancer J Clin 2007; 57:75. Copyright &copy; 2007 John Wiley &amp; Sons, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12188=[""].join("\n");
var outline_f11_57_12188=null;
var title_f11_57_12189="ESC surgery for primary MR";
var content_f11_57_12189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F86954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F86954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    European Society of Cardiology guideline recommendations for mitral valve surgery in patients with severe primary mitral regurgitation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"70%\">",
"     </colgroup>",
"     <colgroup span=\"3\" width=\"10%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Class*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Levels",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ref",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Mitral valve repair should be the preferred technique when it is expected to be durable.",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Surgery is indicated in symptomatic patients with LVEF &gt;30 percent and LVESD &lt;55 mm.",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        B",
"       </td>",
"       <td>",
"        1,2",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Surgery should be considered in asymptomatic patients with preserved LV function, high likelihood of durable repair, low surgical risk and flail leaflet and LVESD &ge;40 mm.",
"       </td>",
"       <td>",
"        I",
"       </td>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Surgery should be considered in patients with severe LV dysfunction (LVEF &lt;30 percent and/or LVESD &gt;55 mm) refractory to medical therapy with high likelihood of durable repair and low comorbidity.",
"       </td>",
"       <td>",
"        IIa",
"       </td>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Surgery is indicated in asymptomatic patients with LV dysfunction (LVESD &ge;45 mm and/or LVEF &le;60 percent).",
"       </td>",
"       <td>",
"        IIa",
"       </td>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Surgery should be considered in asymptomatic patients with preserved LV function and new onset of atrial fibrillation or pulmonary hypertension (systolic pulmonary pressure at rest &gt;50 mmHg).",
"       </td>",
"       <td>",
"        IIa",
"       </td>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Surgery may be considered in patients with severe LV dysfunction (LVEF &lt;30 percent and/or LVESD &gt;55 mm) refractory to medical therapy with low likelihood of durable repair and low comorbidity.",
"       </td>",
"       <td>",
"        IIb",
"       </td>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Surgery may be considered in asymptomatic patients with preserved LV function, high likelihood of durable repair, low surgical risk, and:",
"        <ul>",
"         <li>",
"          Left atrial dilatation (volume index &ge;60 ml/m",
"          <sup>",
"           2",
"          </sup>",
"          BSA) and sinus rhythm, or",
"         </li>",
"         <li>",
"          Pulmonary hypertension on exercise (SPAP &ge;60 mmHg at exercise).",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        IIb",
"       </td>",
"       <td>",
"        C",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    1. Haan CK, Cabral CI, Conetta DA, Coombs LP, Edwards FH. Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 2004;78:820&ndash;825.",
"    <br>",
"     2. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR, Frye RL. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994;24:1536&ndash;1543.",
"     <div class=\"footnotes\">",
"      BSA: body surface area; LV: left ventricle; LVEF: left ventricular ejection fraction; LVESD: left ventricular end-systolic diameter; SPAP: systolic pulmonary artery pressure.",
"      <br>",
"       * Class of recommendation.",
"       <br>",
"        <font class=\"bullet\">",
"         &bull;",
"        </font>",
"        Level of evidence.",
"        <br>",
"         &Delta; Reference(s) supporting class I (A + B) and IIa + IIb (A + B) recommendations.",
"        </br>",
"       </br>",
"      </br>",
"     </div>",
"     <div class=\"reference\">",
"      From: Vahanian A, Alifieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012; 33:2451. By permission of European Society of Cardiology. Copyright &copy; 2012 Oxford University Press.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12189=[""].join("\n");
var outline_f11_57_12189=null;
var title_f11_57_12190="Health literacy level";
var content_f11_57_12190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56350&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56350&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Total US population: number and percentage of adults in each health literacy level: 2003",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 233px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A majority of adults had",
"    <em>",
"     Intermediate",
"    </em>",
"    heath literacy. Over 75 million adults combined had",
"    <em>",
"     Basic",
"    </em>",
"    and",
"    <em>",
"     Below basic",
"    </em>",
"    health literacy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: National Center for Education Statistics. Available at file://nces.ed.gov/naal/health_results.asp.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12190=[""].join("\n");
var outline_f11_57_12190=null;
var title_f11_57_12191="Component separation technique rectus muscle elevation";
var content_f11_57_12191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F55185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F55185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Component separation technique rectus muscle elevation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When additional advancement is needed while performing the component separation technique, the rectus muscle can be elevated from the posterior sheath in its entirety. The anterior rectus fascia remains intact.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Nguyen VT and Shestak KC. Separation of anatomic components method of abdominal wall reconstruction--clinical outcome analysis and an update of surgical modifications using the technique. Clin Plast Surg. 2006; 33:247.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_57_12191=[""].join("\n");
var outline_f11_57_12191=null;
